Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2023 Jun 23;24(7):2957–2981. doi: 10.1021/acs.biomac.3c00098

Versatile Potential of Photo-Cross-Linkable Silk Fibroin: Roadmap from Chemical Processing Toward Regenerative Medicine and Biofabrication Applications

Jhaleh Amirian †,, Jacek K Wychowaniec §, Ehsan Amel Zendehdel , Gaurav Sharma ⊥,#, Agnese Brangule †,‡,*, Dace Bandere †,‡,*
PMCID: PMC10336850  PMID: 37353217

Abstract

graphic file with name bm3c00098_0009.jpg

Over the past two decades, hydrogels have come to the forefront of tissue engineering and regenerative medicine due to their biocompatibility, tunable degradation and low immunogenicity. Due to their porosity and polymeric network built up, it is possible to incorporate inside drugs, bioactive molecules, or other biochemically active monomers. Among biopolymers used for the fabrication of functional hydrogels, silk fibroin (SF) has received considerable research attention owing to its known biocompatibility and tunable range of mechanical properties. However, its relatively simple structure limits the potential usability. One of the emerging strategies is a chemical functionalization of SF, allowing for the introduction of methacrylate groups. This allows the versatile processing capability, including photo-cross-linking, which makes SF a useful polymer as a bioink for 3D printing. The methacrylation reaction has been done using numerous monomers such as methacrylic anhydride (MA), 2-isocyanatoethyl methacrylate (IEM), or glycidyl methacrylate (GMA). In this Review, we summarize the chemical functionalization strategies of SF materials and their resulting physicochemical properties. More specifically, a brief explanation of the different functionalization methods, the cross-linking principles, possibilities, and limitations of methacrylate compound functionalization are provided. In addition, we describe types of functional SF hydrogels and link their design principles to the performance in applications in the broad fields of biofabrication, tissue engineering, and regenerative medicine. We anticipate that the provided guidelines will contribute to the future development of SF hydrogels and their composites by providing the rational design of new mechanisms linked to the successful realization of targeted biomedical application.

1. Introduction

In recent years various types of hydrogels based on natural and synthetic polymers were employing multiple different cross-linking mechanisms.13 It has been shown that the appropriate choice of chemical cross-linking approach leads to the generation of hydrogel networks with properties tailored to the desired clinical or tissue engineering application.46 Among all types of hydrogels, peptide- and protein-based hydrogels have been widely studied as biocompatible matrices for numerous biomedical applications.2,712 These molecules typically form safe and effective biomaterials due to their ability to form stable networks under mild conditions, their excellent intrinsic biocompatibility, as well as tunable biochemical and biophysical properties.1,2,5,812 Their physical and biochemical properties depend on the composition, the polymerization method, and the type and degree of cross-linking.5 The utilization of cross-linking approaches has led to the development of many applications for these hydrogels in biomedical science, especially in designing injectable cell and drug cargo vehicles.1,6,10 Moreover, they have become an integral part of 3D culture research to investigate the cellular proliferation and migration as well as interactions between encapsulated cells (cell–cell) and cells with the matrix (cell–material).8,10 Since they mimic the structure and characteristics of extracellular matrix (ECM), they appear as ideal mimicking biomaterials for many biomedical applications.1,2,6,11,12

Silk fibroin (SF) is a protein-based biopolymer that shows good biocompatibility, adjustable biodegradability, and low immunogenicity.13,14 These characteristics make it suitable to form hydrogels for the use as a versatile tissue engineering support. It has been reported that SF has been used as scaffolds/fibrous membranes,15 hydrogels,16 in animal models for bone17 and cartilage tissue engineering,18 wound healing,16,19 and as hemostatic agents.20 On the other hand, many studies have shown that the regenerated SF materials still lack suitable mechanical properties for the targeted application.21 It should be noted that degumming process conditions can significantly change the physicochemical and mechanical properties of silk fibers when silk sericin (SS) is removed completely.22 Various approaches have also been employed to use SF as a bioink,23,24 including enzymatic cross-linking, chemical modifications, and compositing with other materials.25

Here we present a review of recent studies on the synthesis, characterizations, and biomedical applications of photo-cross-linkable silk fibroin-based materials synthesized by the introduction of methacrylic anhydride (MA),26 glycidyl methacrylate (GMA),2734 2-isocyanatoethyl methacrylate (IEM),3538 carbic anhydride (CA),39,40 and norbornene (NB) to create photo-cross-linkable materials. Often these are reported and abbreviated as methacrylated silk fibroin (SFMA), methacrylated silk fibroin sealant (Sil-MAS), silk fibroin methacrylate (SF-IEM), norbornene-functionalized silk fibroin (SF-NB), or silk fibroin methacrylate (SF-GMA). Based on the fact that SFMA is a derivative of silk fibroin, we suggest “methacrylated silk fibroin” would be the most appropriate name, which also matches the widely accepted abbreviation SFMA.

As a result of photoinitiated radical polymerization, SFMA forms hydrogels with covalently bonded networks. SFMA hydrogels, in the presence of a photoinitiator, can be covalently cured by directly exposing them to UV or visible light. Based on studies previously conducted, SFMA shows greater mechanical strength in comparison to other types of methacrylated hydrogels, such as gelatine methacrylate (GelMA).5,24 Apart from its ability to covalently bond when exposed to UV light or visible light, the mechanical properties of the SFMA also come from the physical entanglements of SF molecules through the conformational interactions of its β-sheet.41 Photopolymerization can occur at mild conditions (room temperature, neutral pH, aqueous environments, etc.) and can be regulated spatiotemporally.29,33,34 Therefore, SF provides opportunities as an ideal platform for manipulating cellular behavior, studying the interaction of cells and engineering tissues using bio- or microfabrication approaches.

The objective of this Review is to provide an overview of recent studies related to SFMA hydrogel synthesis, characterization, and formation of its composites with other widely used materials. Here, we (1) review the recent studies related to the SF degumming and extraction methods, and present their advantages and disadvantages; (2) review the current trends for modification of the SF for the preparation of the photo-cross-linkable bioinks based on SF; (3) discuss the latest methodology proposed for microfabricating the SFMA hydrogel as well as the benefits of resulting SFMA-based biomaterials; and (4) summarize the most recent developments in SFMA-based hydrogels in different aspects of tissue engineering and regenerative medicine and link their performance to the structural and fabrication aspects discussed with respect to points 1–3.

1.1. Silk Protein Source and Structure

Silk is produced from various sources, including silkworms, spiders, and mites from the phylum Arthropoda, and materials produced from all of these have received a lot of attention in tissue engineering and regenerative medicine.4244 Some of the most common types are shown in Figure 1A and include the following:

  • I.

    SF is derived from Bombyx mori silkworms. It is also known as mulberry silk. They were also used in the textile industry because they could be produced in large quantities.43

  • II.

    The SF derived from other animals (nonmulberry silk) is characterized by polyalanine repeats throughout the crystal structure. Nonmulberry silk includes Antheraea mylitta (tasar), Antheraea assamensis (muga), Antheraea pernyi, Samia cynthia ricini (eri), and others.45 Silk from the silk moth Antheraea assamensis from India is unique among all kinds because it also contains RGD adhesive binding epitopes missing in the mulberry silk.43

  • III.

    There are only genetically engineered options for dragline silk derived from spiders such as Nephila clavipes and Araneus diadematus.43,46 Silk spiders are light, strong, elastic, and have high mechanical properties comparable to some polymers, such as kevlar.4648

Figure 1.

Figure 1

An illustration of (A) silk’s natural source, (B) raw silk fibers consist of fibroin fibers coated with sericin before and after degumming, representative fibroin polymers consisting of silk I and silk II, (C) SF H- and L-chains with hydrophilic and hydrophobic units at the N- and C-terminus, and (D) amino acids of the H chain of SF with reactive and nonreactive portions, along with representative functional groups present in SF for chemical modification and cross-linking figure created with Biorender.com.

Silk is primarily consisting of SF and SS, with SF being the main component of the material, typically constituting about 75% of it (Figure 1B).49 Silk is one of the strongest fibers known to nature, with a tensile strength of up to 4.8 GPa and a density of 1.3 g/cm3.50 It consists of repetitive hydrophobic modules and small hydrophilic groups (Figure 1C).51 A part of the repetitive hydrophobic part of the sequence is composed of amino acids with short side chains, including glycine (Gly) and alanine (Ala). In contrast, the hydrophilic groups are composed of larger side chain polar amino acids.52

The SF contains different functional groups, such as hydroxyl, carboxyl, and amine groups (Figure 1D), which can be further reacted with other chemical species, e.g., using coupling reactions.24 There are three major amino acids found in SF from Bombyx mori, which are Gly (43–46%), Ala (25–30%), and Ser (12%). SF contains over 5000 amino acids, including reactive and nonreactive amino acids. On the basis of previous research, SF contains 1105 of the 5000 reactive amino acids.24 While Gly and Ala are nonreactive, serine (Ser), threonine (Thr), aspartic acid (Asp), glutamic acid (Glu), and tyrosine (Tyr) are reactive parts of the SF that can all be easily chemically modified (Figure 1B,D).53 It was found that an amorphous and crystallized region exists within the structure of SF. Foremost, these crystalline structures consist predominantly of β-sheet structures, with a dominant conformation of β-turns (referred to as silk I) and a folded β-sheet structure (referred to as silk II), schematically depicted in Figure 1B.54 While the exact secondary composition of SF consist predominantly of β-sheets, lower amounts of secondary structures, including α-helices (primarily 31-helices), and an unordered structure exist and are typically found in the silk I region. The exact proportion of each secondary structure depends on the original source of SF, as well as the processing method and environment it is placed in (e.g., salt content or type of solvent).54,55 Originally, SF was referred to as an α-form at an early stage to distinguish it from the β-form (silk II). Therefore, to avoid confusion between the α-form and the α-helix, the term silk I was introdocued for SF before spinning. However, there are a number of papers that suggest that the structure of silk I consists partly of α-helices based on IR and Raman spectra.5457 On the other hand, several studies identified the silk I structure as a type II β-turn, which was thoroughly confirmed using a variety of solid-state NMR and solution NMR techniques along with carefully chosen stable isotope-labeled model peptides.58 Vass et al. came to the conclusion that the silk I structure should predominantly consist of a type II β-turn with a minor abundance of α-helices,59,53 hence, our representation in Figure 1C, stemming from different predominant conformations noted.60 Silk I has a metastable form, which is water-soluble, whereas silk II has the most stable structures and is not soluble in water.60 Silk II and SF chains are linked by hydrogen bonds; the β-sheet motif of SF is a physically cross-linked material that connects together SF molecules into a 3D network, ensuring the strength and durability of the formed hydrogels.60 In contrast, amorphous structures that include α-helices, random coils, and type II β-turns typically have a lower stability than crystalline structures.60 As SF consists of hydrophobic as well as hydrophilic regions, the hydrophilic regions are responsible for the material’s water solubility, elasticity, and toughness.60 Hydrophobic regions have an ability to form intermolecular interactions, resulting in a conformational change from random-coils or α-helix to a β-sheet motif, depending on the external environmental conditions.60,61 SF consists of a heavy (H)-chain of approximately 350 kDa and a light (L)-chain of approximately 25 kDa, which are bridged by a disulfide bond, as depicted in Figure 1D.47,52,62

1.2. SF Extraction Method

Extracting SF from silk glands or silkworm cocoons can be accomplished in several ways. A key step in this process involves removing sericin from the cocoons (“degumming”) and subsequently dissolving and purifying them.63,64 There are numerous ways that the SF can be degummed, including by acids,63,65 alkalines,63 soaps,63,65 amines,63,66 enzymes,63,67 urea,68 sodium carbonate,64,65 ultrasonication,63,69 autoclaving,68 carbon dioxide (CO2) supercritical fluids,63,70 and boiling,71 all as shown in Figure 2. In Table 1, we provided a list of some of the advantages and disadvantages of each degumming approach. When degumming is being carried out in the textile industry, boiling water or detergent solutions are used as the method of cleaning. However, as part of these methods of removing sericin in the laboratory, boiling in sodium carbonate and autoclaving are among the most widely used.47 Studies have indicated that sodium carbonate dissolved in boiling water is the most commonly used method for degumming silk for biomedical applications. Silk fibers which have been degummed are generally dissolved in inorganic salts such as high concentrations of LiCl,72 LiBr solution,73,74 NaSCN solution,75 ZnCl2 solution,76 or in a ternary solvent mixture comprising CaCl2/ethanol/water.47,64,68,77 Salts such as these are also capable of breaking hydrogen bonds, ultimately disassembling the β-crystalline structure of degummed silk. Purification is carried out by dialysis against water and removing salts and impurities in order to obtain pure SF.64 Moreover, SF can be extracted and stored in lyophilized form for long-term storage and, later on, can be dissolved in organic solvents such as HFIP (1,1,1,3,3,3-hexafluoro-2-propanol)78 and formic acid79 to produce SF scaffolds in different forms including fibers, gels, or sponges.

Figure 2.

Figure 2

Illustration of an alternative degumming technique for silk. Figure created with Biorender.com.

Table 1. Comparison between Common Degumming Methods for SF.

degumming method reagents advantages drawbacks ref
alkaline degumming Na2CO3 strong and effective action possibility of fibroin damage (69,80)
NaHCO3 fast procedure decreasing fibers strength
Na2HPO4 more cost-effective β-sheet structure severely damaged
Na3PO4 lowering molecular weight time consuming
Na2[B4O5(OH)4]·8H2O a simple approach sericin degradation
acid degumming tartaric acid improvement in tensile strength slight decrease in dye uptake (69,81)
lactic acid
citric acid restricted hydrolysis
oxalic acid the degumming bath can be reused
malonic acid
succinic acid
trichloroacetic acid
dichloroacetic acid
monochloroacetic acid
glacial acetic acid
soap degumming marseille, sodium laurate, sodium myristate, sodium stearate whitening and brightening silk the degumming bath is not reusable (63,82)
excellent strength, elasticity effluent problems
avoids fiber coagulation metal ions in water can form insoluble metal soaps on silk
enzymatic degumming papain eliminates uneven dyeing simple enzyme deactivation (67,71)
trypsin
proteases enhances dye affinity (especially with reactive dyes) expensive
completely removes sericin risk of overreaction with fibers
environmentally friendly not suitable for large-scale commercial production
works at a moderate pH and temperature not efficient in removing hydrophobic impurities
amine degumming methylamine providing undamaged and uniform silk not easily applicable to industry (63,66)
ethylarnine fibers low degumming rate
diethylamine water does not affect degumming  
triethylamine whitening and brightening silk unpleasant odors
marseilles soap shorter processing times
lower temperature and less time required than soap degumming
carbon dioxide supercritical fluid degumming CO2 maintains the purity of sericin as well high costs and processing demand of high-tech equipment (70)
contamination-free
reduced amount of wastewater
low energy consumption
degumming by urea   high reproducibility undesirable degradation of SF (83)
SS produced by urea degumming has higher antityrosinase activity than SS produced by Na2CO3 degumming
high temperature and pressure (autoclaving)   highly efficient removing only the outer layer of sericin (68,71)
no contamination effects absorbency and whiteness
without contamination
cost-effective method
ultrasonication   environmentally friendly adding soap, alkali, acid, or enzyme is required (69,84)
improved energy efficiency
reduced chemical usage utilization of electrical energy for acoustic purposes
increasing productivity

2. Chemical Modification of the SF for Introducing the Methacrylate Group

There are numerous techniques used to introduce functional methacryloyl groups into SF, which render SF a photo-cross-linkable polymer.85 There are primarily two ways for photopolymerizing SF-based macromonomers. As a first method, the reducing agents (for example, ruthenium complexes) can be used to photopolymerize pristine SF, resulting in covalent bond formation.86,87 This approach uses for example the presence of tyrosine on pristine SF, which can easily form dityrosine bonds when catalyzed with a ruthenium complex under light exposure. A second approach involves prechemical modification of SF protein, where active amino acids are used for the grafting of other functional groups, such as methyl methacrylate,88 vinyl acrylate,89 and methacrylic acid derivatives.5,85,90,91 Consequently, modified SF chains are photopolymerized in the presence of the photoinitiator under UV or visible light irradiation. Using the second approach, which is the main objective of the current review, the modified SF can be precisely tuned in terms of its physicochemical properties, chemical strength, hydrophilicity, and swelling behavior in order to meet the needs of specific tissue engineering applications. SF has an amino acid sequence that consists of approximately 12% serine, 0.3% arginine, and 0.2% lysine.24,26,53,92 Nucleophilic hydroxyl groups are weakly present in serine residues, while amino groups are strongly present in lysine and arginine residues.26 As a result, covalent bonds may form between these functional groups and reactive electrophiles, such as IEM.26 Hence, a chemically modified SF derivative can be produced.90 Free-radical polymerization can be readily performed by the grafting of materials containing double C=C bond groups, such as methacryloyl groups, on polymer chains. Several studies have been conducted based on the preparation of the photo-cross-linkable SF by incorporating the MA,26,93 and GMA,24,86 and IEM, on the SF chain. Depending on the conditions and modification reagents, methacryloyl substitution can be carried out at its amine, hydroxyl, and carboxyl groups. Until now, the components used to introduce methacryloyl groups on SF are MA, GMA,86 and IEM. However, these chemicals have been shown to induce different effects on SF properties. In the process of methacrylating SF by MA, a byproduct known as methacrylic acid is formed, resulting in a reduction of pH and crystallization of SF. A methacrylation of SF by GMA is based on an epoxide ring opening, and this type of reaction does not produce any byproducts, causing a reduction of pH, making this a more facile type of methacrylation. MA and GMA are both proposed to react with the primary amines of SF that constitute around 0.2% of its total amino acid content.86,94 Among typical reactive amino acids, the primary amino acid groups are lysine 0.2%, arginine 0.3%, asparagine 0.4%, and glutamine 0.2%, with lysine being the predominant amino acid participating in MA and GMA reactions. GMA is also capable of reacting with carboxyl and hydroxyl groups which are present in SF.12,24,53,95 Based on a recent report, GMA can react with carboxyl and hydroxyl groups either via transesterification or opening of the epoxide ring.96,94 The SF heavy chain contains a higher molar ratio of hydroxyl and carboxyl groups, approximately 19.4%, and a lower molar ratio of primary amine groups (lysine 0.2%). As a result, methacryloyl substitution on the carboxyl and hydroxyl groups may lead to an increase in cross-linkable sites in SF, meaning an increase in photo-cross-linking density, which can be reflected in the final mechanical properties of the formed hydrogels. In subsequent sections, we provide a detailed analysis of these reactions.

2.1. How Modification Reactions are Performed

In Figure 3 we schematically depict all the most important methacrylation reactions, providing basic information about the methacrylation agents that are used, typical conditions, as well as providing exemplar NMR spectra, confirming successfully utilized reactions. In the following sections, we discuss each type of reaction in more detail.

Figure 3.

Figure 3

(A) Diagrams of various approaches for modifying the SF with monomers containing double bonds, including MA, IEM, GMA, and NB, to produce photo-cross-linkable SF materials, (B) achieved methacrylation by each method (NM: not mentioned), and (C) SFMA chemical reactions and their representative NMR compared to SF. Adopted with permission from ref (93). Copyright 2021 Wiley-VCH GmbH. Adopted with permission from ref (35). Copyright 2018 Elsevier Ltd. Adopted with permission from ref (32). Copyright 2021 American Chemical Society. Adopted with permission from ref (39). Copyright 2016 The Royal Society of Chemistry. Except the adopted NMR spectra with listed copyright permissions, figure was created with Biorender.com.

2.1.1. Modification by MA

The MA has been used in numerous studies for the methacrylation of gelatin (i.e. to synthesize GelMA).5,97 The MA is a relatively inexpensive and stable methacrylating agent compared e.g. to the IEM, and can be used in aqueous solutions, which overall makes it a primary choice of methacrylation agent.26 Bessonov et al. reported the first instance of methacrylation of the SF with MA in 2019.26 By this method, SFMA is synthesized by direct reaction of SF with MA in a potassium phosphate buffer solution (at pH = 7.0) at 50 °C for 1 h under vigorous stirring.26 With this reaction, the methacryloyl groups are introduced on the reactive amines of the residues of amino acids present in SF. Noting that the total amount of amine in SF is approximately 0.2%, this is a maximum limit of the degree of methacrylation, overall being low compared to many other biopolymers.98,99 Nevertheless, we expect the possibility to modulate it within this range by other factors, such as controlling temperature or the total time of the reaction. So far only two studies focused on the methacrylation by means of MA, however, no information has been provided on the final achieved degree of methacrylation.26,93 Consequently, it is possible the minor variation in the degree of methacrylation in this range may result in SFMA products with lower number of cross-links and thus variable mechanical properties when subsequently photo-cross-linked. This variation however has not yet been reported, as degrees of methacrylation in the two reports were not provided. A stop-reaction is accomplished by diluting the reaction mixture (roughly two times) with potassium phosphate buffer solution, followed by several days dialysis against water through cellulose cutoff tubing to remove residual impurities, including unreacted MA, methacrylic acid, and other byproducts of the reaction (Figure 3A). As a final step, the dialyzed solution is frozen and lyophilized for long-term storage of a product reconstituting solid (Figure 3B).26 However, MA has not been extensively employed for methacrylation of the SF due to the resulting lower degree of methacrylation and reported reduction of efficiency of the reaction caused by the decrease of pH from the resulting methacrylic acid byproduct.

2.1.2. Modification by IEM

IEM is one of the methacrylation reagents, which is used for methacrylation of SF.38 Since IEM is an electrophilic compound, it is capable of reacting with both weak hydroxyl groups and strong nucleophiles (amino groups in lysine and arginine residues) at comparable rates.26 Unlike the MA reaction, which can be conducted in an aqueous medium, methacrylation by IEM should be carried out in anhydrous dimethyl sulfoxide (DMSO).26 A study by Kurland and colleagues reports the synthesis of silk fibroin-based photoresist materials by the use of IEM.37 A general way to conduct this type of reaction is to dissolve SF in a solution that contains 1 M lithium chloride dissolved in dimethyl sulfoxide (LiCl/DMSO; Figure 3A)35,37,38 or HFIP.36 Afterward, IEM was added, and the reaction was stirred for 1–5 h in a nitrogen gas atmosphere at 60 °C. For various methacrylation degrees, different amounts of IEM, between 0.25 and 2.0 mM per gram of SF, were added to the solution. Upon stopping the reaction by adding 10 X dilution of deionized (DI) water, solution was dialyzed at room temperature for 3 days with a cellulose acetate membrane (MWCO: 12–14 kDa). In the next step, the solution was centrifuged and finally freeze-dried (Figure 3A). It is also noteworthy to mention that methacrylation using IEM produces macromers composed largely of urethane-acrylates rather than methacrylamides.26 Due to the expanded capability of IEM reacting, higher degrees of methacrylation are obtained than in the case of MA, with values up to 9.3% reported (Figure 3B).35

2.1.3. Modification by GMA

Another substance that has recently received a lot of attention for the functionalization of SF is GMA.12,31,99 In this method SFMA is synthesized by reacting SF with GMA in lithium bromide with a concentration of 9.3 M at 60–65 °C for 1–4 h under vigorous stirring conditions (Figure 3A).24,2733 The degree of methacrylation will be dependent on the primary amine on lysine and will occur through the ring-opening of epoxy at GMA.24 However, based on the recent report, GMA can also react with other groups, such as carboxyl and hydroxyl, either via transesterification or the opening of the epoxide ring. The SF heavy chain contains a higher molar ratio of hydroxyl and carboxyl groups, approximately 19.4%, and a lower molar ratio of primary amine groups (lysine 0.2%). As a result, methacryloyl substitution on the carboxyl and hydroxyl groups may lead to an increase in cross-linkable sites in SF, meaning an increase in photo-cross-linking density (Figure 3B,C). Various concentrations of GMA with respect to SF and stirring (reaction) time are added to achieve different levels of methacrylation. As the methacrylation takes place through the opening of the epoxide ring, there are no byproducts generated that would reduce the pH of the final solution. In 2018, Kim et al. reported this method of methacrylation of SF using GMA in order to prepare 3D-printed bioink for printing highly complex organ structures, such as the ear, vessel, brain, and trachea.24 GMA was added in various molar ratios to SFMA to investigate the influence of methacrylation level on final bioink physicochemical properties, structure, and their biocompatibility. Kim et al. synthesized SFMA hydrogels with different methacrylation degrees (22.4, 32.2, 42.0, and 39.2%), using 141, 282, 424, and 705 mM GMA solutions in the reaction, respectively.24 Noteworthy, there was no linear relationship noted in this case and highest degree of methacrylation was obtained for 424 mM of GMA. This enables control over how the characteristics of SFMA can be altered through manipulation of its synthesis approaches, methacrylation agents, and processing. In another report by Costa et al., SFMA hydrogel mechanical properties were correlated to a degree of methacrylation.27 The SFMA bioink with a higher methacrylation degree, 63.5%, has shown denser and smaller pore size structure, higher mechanical strength, 24.4 ± 2.8 kPa, and lower swelling ratio, as compared to SFMA with lower methacrylation, 44.5%, with larger pores, and lower mechanical strength, 5.4 ± 0.3 kPa (Figure 4A–C). It is obvious that the degree of methacrylation has an effect on the degree of conformation change that occurs after cross-linking with UV light. When a color change occurs, it indicates the transition between a random coil and a β-sheet. SFMA that is highly methacrylated maintains its transparency, while SFMA that is moderate and has a low degree of methacrylation produces an opaque white color within a short period of time (Figure 4B). A high degree of methacrylation results in smaller pores in SFMA, which results in lower swelling ratios for SFMA constructs (Figure 4D).

Figure 4.

Figure 4

Material characterization of SFMA bioink (SFMA: GEL: GLY (16:4.5:8% (w/v)) constructs with different degrees of methacrylate (H: high, M: moderate, and L: low): (A) scanning electron micrographs, (B) changes in the conformation during incubation at 0, 1, 7, and 14 days, (C) compressive elastic moduli after 0, 1, 7, and 14 days incubation, (D) swelling ratio of hydrogel after 14 days. Adopted with permission from ref (27). Copyright 2020 American Chemical Society. Representative material properties of SFMA (15%) hydrogel at three different pH levels: (E) compressive moduli, (F) hydrogel conformational changes during 28 days incubation in PBS, (G) hydrogel toughening effects after 0, 7, and 14 days incubation, and (H) SFMA swelling properties in PBS. Adopted with permission from ref (30). Copyright 2021 American Chemical Society.

Barroso et al. investigated how three different pH values (5, 7, and 8) can affect the rheological properties, compressive modulus, and network swelling of SFMA hydrogels synthesized by means of GMA.30 The corresponding values for SFMA hydrogels compressive modulus were 40 ± 4 kPa at lower pH (pH 5) in comparison to 21 ± 2 kPa at higher pH (pH 7), as shown in Table 2.30 A two-orders of magnitude increase in SFMA compressive modulus (at pH 5) was observed within 14 days, and a one-order of magnitude increase in SFMA compressive modulus was observed at pH 7 and 8, as shown in Figure 4G. The compressive modulus of SFMA hydrogels prepared at pH 7 and 8 were in fact not statistically significant between days 0 and 7. Figure 4H illustrates the swelling ratio for SFMA at pH 7 and 8, which shows significant increases (2-fold) compared to SFMA at pH 5. In summary, this study showed that the swelling characteristics of the hydrogel were directly correlated to the pH.

Table 2. Brief Summary of the Type and Concentration of SFMA and Photoinitiator, Wavelength, Intensity, and Time Used for Photo-Cross-Linking in SFMAa.
  hydrogel % (w/v)       rigidity
 
grafted monomer photoinitiator % (w/v) photoinitiator wavelength/irradiation power time     ref
MA SFMA/SFMA-Ce6 7.5% and 10% Irgacure 2959 365 nm 60 s 7.5 326 kPa (93)
10 553 kPa
0.5%   30 mW/cm2  
MA 10% w/v TPO UV light 10 min HFIP 480 kPa (26)
FA 120 kPa
0.5% w/v   NM  
IEM 2% Irgacure 2959 365 nm 1.5 s NM (36)
0.6% 2 mW/cm2  
IEM 2% Irgacure 2959 320–500 nm 1 s 0.6 15.6 ± 1.1 GPa (37)
0.6% NM  
IEM 12, 20, 28% (w/w) FFP blended with eumelanin Irgacure 2959 365 nm 3 s NM (38)
2.5% (w/v) 20 mW/cm2    
IEM 10–20 wt % LAP 365 nm 5 min NM (35)
1 mM 5 mW/cm2  
GMA electrospun fiber FMN 454 nm 10 min NM (34)
2 mM of FMN  
50 mM of SPS SPS 2500 mW/cm2
GMA 25% LAP 365 nm 10–30 s NM (33)
0.3% 6 mW/cm2  
GMA 15% LAP 365 nm 5 min pH 5 40 ± 4 kPa (30)
3 mW/cm2 UV-A pH 7 21 ± 2 kPa
pH 8  
0.5%   3 mW/cm2  
GMA 20% LAP 365 nm NM   (32)
0.2% 1300 MW  
GMA 10 and 20% LAP NM NM   (31)
5 and 75 mg  
GMA 0.3% or 0.03% LAP 365 nm 10 min NM (29)
0.2% or 0.04% NM  
GMA 20% LAP NM 200 s   (28)
0.3% 4.79 mW/cm2  
GMA SFMA:GEL:GLY 16:4.5:8% (w/v) Irgacure 2959 BlueWave MX–1 50 LED 120 s 14.7 ± 2.1 kPa (27)
0.1% 400 mW/cm2  
CA SFNB 1% LAP 365 NM 5 min   (39)
1 mM 5 mW/cm2  
CA SFNB: 5–15 wt % DTT (DTT: SFNB with 1–10 to 1:50 mass ratio) 0.05–0.5 wt % Irgacure 2959 NM NM 1:10 0.9 Pa (40)
1:50 1.1 kPa
a

NM: not mentioned.

2.1.4. Modification by NB

Ryu and co-workers described a new synthesis route for the preparation of norbornene functionalized silk fibroin (SFNB). To carry out the modification, the primary amines of the SF are used as nucleophiles for the reaction with CA, resulting in the formation of amino-linked norbornene (NB; Figure 3). The preparation of SFNB can be summarized as follows: SF is reacted with carbic anhydride in aqueous buffer solutions (pH 9) and borate, which are stirred overnight at room temperature in the dark (Figure 3A). As the last step, the solution is filtered and dialyzed against deionized water at 4 °C for 3 days using cellulose acetate tubes (MWCO: 12–14 kDa; Figure 3B). The prepared SF-NB hydrogel shows dual mode gelation behavior, including chemical and physical cross-linking. This dual mode cross-linking is based on thiol–ene photoclicking chemistry and β-sheet formation of the SF.39 Contrary to the methacrylate, the norbornene group exhibits less toxicity to cells and are capable of selectively reacting with thiols.100 As a consequence, more selective topological gel networks can be formed, since photopolymerization of the same polymer chains is prevented.100 Although thiol–ene photoclicking chemistry is different to that of methacrylated moieties, we briefly summarize this here as an addition to the emerging types of chemistries that is expected to be frequently used in the near future.

2.2. Photoinitiators Used for Cross-Linking SFMA

SFMA can be photo-cross-linked using multiple photoinitiators that can be cured under light exposure, most commonly at two wavelengths of either λ = 365 or 405 nm. A number of photoinitiators are frequently used in the cross-linking of SFMA, including 2-hydroxy-1-[4-(2-hydroxyethoxy) phenyl]-2-methyl-1-propanone (Irgacure 2959).3638,40,93 and lithium acylphosphinate salt (LAP).2833,35,39 In aqueous environments, the solubility of Irgacure 2959 in water is much lower (around 5 mg/mL) than that of LAP (around 885 mg/mL), however, these are sufficiently high for the photopolymerization to occur. Other types of photoinitiators were also used, such as diphenyl-(2,4,6-trimethylbenzoyl) phosphine oxide (TPO),26 flavin mononucleotide (FMN),34 and sodium persulfate (SPS).34 There are many factors, such as SFMA concentration, photoinitiator concentration, UV exposure time, and radiation power of the light, that allow tuning of the physical properties of the resulting SFMA hydrogels. We summarized those and their influence on final structural properties in Table 2. The amount of photoinitiator used in SFMA affects the overall cross-linking time, quality, final degradation as well as color of the resulting hydrogels. Bucciarelli et al. have looked at how the percentage of LAP affects the color of SFMA hydrogels.31 It is likely that this change in color is related to a cross-linking or reaction occurring between SFMA chains in the presence of LAP. It was observed that UV treatment of SFMA samples with high amounts of LAP (15% w/w) resulted in a photoyellowing effect; however, this effect was not observed with SFMA samples with low amounts of LAP (1% w/w).31 It has been reported that the impact of UV radiation on amino acids depends on three factors: time, energy absorbed, and peak-wavelength.101 Photoyellowing is primarily related to free radical photooxidation of tryptophan and tyrosine residues which leads to yellow products. In this respect, it could be possible that LAP induces the oxidation of tyrosine and tryptophan residues.31,101 It is, however, noteworthy to add that 15% w/w concentrations of LAP are beyond the standard regime of low cytotoxicity and would not be used in any biomedical settings. Concentrations lower than 1% w/w should remain the only viable options in future studies to limit any potential cytotoxicity effects.

2.3. Hybrid and Composite Hydrogels Based on Photo-Cross-Linkable SF

Typically, hybrid and composite hydrogels are constructed from the combination of a variety of components that have been chosen to synergize the properties of each component in a single biomaterial.5 SFMA has also been used in the form of the composite with other types of the synthetic and natural polymers. Here we summarize composite hydrogels composed of SFMA and other compounds, such as N,N-dimethylacrylamide (DMAA), tetramethylethylenediamine (TEMED), polyethylene glycol diacrylate (PEGDA), graphene oxide (GO), and inorganic and organic nano- and microparticles, such as methacrylated hollow mesoporous silica microparticles (HMSC-MA), as well as molecularly imprinted silk.

Costa et al. coprinted porcine primary meniscus cells (pMCs) using gellan gum/fibrinogen (GG/FB) composite bioinks in conjunction with SFMA bioink hydrogels to produce an elastic hybrid construct for advanced fibrocartilaginous tissue regeneration (Figure 5A).27 As we have already shown, in this study different levels of methacrylation exhibited different effects on the rheological properties, swelling ratio, and compressive mechanical behavior of the material (Figure 4 A, B, C, and D).

Figure 5.

Figure 5

Schematic illustration of (A) the hybrid bioinks made from the SFMA:GEL:GLY B bioink and the GG/FB bioink, as well as the scheme of printing, the 3D CAD model, slicing, and 3D printed constructs. Adopted with permission from ref (27). Copyright 2020 American Chemical Society. (B) 3D bioprinted construct is obtained using extrusion bioprinters and SFMA-PEGDA bioink infused with porcine chondrocytes. Adopted with permission from ref (102). Copyright 2021 Wiley Periodicals LLC. (C) SFMA-GO electroconductive bioinks and their characteristic features. Adopted with permission from ref (28). Copyright 2020 American Chemical Society. (D) Stress–strain curves for hydrogels containing various levels of DMAA (inserted images of SFMA hydrogel containing 2% DMAA during 350% elongation). Adopted with permission from ref (107). Copyright 2020 Elsevier B.V. (E) Homogeneous SFMA gel is generated containing nanoparticles of HMSC-MA and CTAB and microextrusion-based 3D printing simultaneously photo-cross-linking hydrogel constructs. Adopted with permission under Creative Commons CC BY-NC 4.0 License from ref (108). Copyright 2022 Wiley-VCH GmbH. (F) SFMA synthesized with GMA and BS-MA using TMSPMA. Adopted with permission from ref (32). Copyright 2021 American Chemical Society. (G) SFMA-Ce6 Hydrogel for treatment of residual melanoma and wound healing. Adopted with permission from ref (93). Copyright 2021 Wiley-VCH GmbH. (H) Dual mode gelation of SFNB-PEGs with thiol–ene photopolymerization and post gelation of SF molecules by hydrogel structural transition in PBS. Adopted with permission from ref (39). Copyright 2016 The Royal Society of Chemistry.

Among the PEG derivatives, PEGDA contains reactive acrylate groups both at the termination ends. This component is widely utilized in the preparation of photo-cross-linkable hydrogels that are cured using light. In addition, PEGDA hydrogels are bioinert, nontoxic, nonimmunogenic, possess tunable physical and chemical properties, and have been shown to be injectable.102,103 Bandyopadhyay et al. have developed a bioink made of composite bioink in order to promote cartilage regeneration (Figure 5B).102 SFMA, PEGDA, and gelatin have been used as the main components of their bioink. The ratio of SFMA to PEGDA was varied between 2 and 8% (w/v) and 25–100 (w/v), respectively, to determine the best concentrations in order to prepare and print the hydrogels. In addition, 20% (w/v) of gelatin (GEL) was blended into the optimized bioink for improved thermal gelation-based printability as well as shear thinning-based shape fidelity, as well as the retention of the printed layers after deposition. The authors have shown that two compositions, SFMA:PEGDA:GEL (w/v%) of 7:60:20 and 8:60:20, show the best gel formation, consistency, and printability among different compositions. In both of these bioinks, the LAP concentration of 0.2% was used. However, there was no information available about the resulting mechanical properties of each gel.

GO is a two-dimensional nanomaterial obtained from the exfoliation-oxidation of graphite and can be incorporated into hydrogels, such as GelMA,5,104 methacrylated chitosan (ChiMA),105 and SFMA28 to form nanocomposites with enhanced mechanical properties.5,105,106 Ajiteru et al. have prepared the composite that is comprised of the SFMA conjugated with graphene oxide (GO), a material that can be utilized as a printable bioink through digital light processing, as shown in Figure 5C. A 0.25% w/v and 2.5% w/v GO was added to the SFMA, resulting in a compressive stress increase to approximately 580 and 770 kPa, which are higher than the pristine SFMA at 550 kPa.28 A further increase in conductivity was obtained by adding GO from 0.25 to 2.5% from 0.005 to 0.0065 S/mm, which is greater than the conductivity of SFMA in its original form, 0.0025 S/mm.28 Between day 0 and day 3, no significant differences were found between SFMA and SFMA containing 0.25 and 2.5% w/v GO. After 3 days, the proliferation of mouse neuroblastoma (Neuro2a) cells increased progressively; SFMA contains higher levels of proliferation than SFMA with 0.25, 2.5% w/v GO. Comparing the synthesized bioink with conventional SFMA, the synthesized bioink has been shown to demonstrate enhanced mechanical strength, electroconductive properties, and neurogenic properties.28

Oral et al. proposed a strategy for the preparation of stretchable SF hydrogels by introducing flexible polymer chains into the brittle SF network, as is shown in Figure 5D. By using this method, it was possible to strengthen the connections between the SF globules. This study reported the use of SFMA and DMAA monomers in combination with TEMED, 1–4-butanediol diglycidyl ether (BDDE), and ammonium persulfate (APS) as cross-linkers, pH-regulators, and initiators, respectively, to construct an interconnected SFMA composite hydrogel network. They found that by incorporation of 2–3% DMMA into the SFMA networks, the brittle hydrogel could be transformed into a stretchable one. A hydrogel containing DMAA had a toughness of 54 kJ/m3, which was 20 times greater than one without DMAA, 2.5 kJ/m3. Additionally, they have shown that SFMA containing 2% DMAA had a greater elongation ratio, approximately 370%, compared to the control SFMA. As a result, the amount of DMMA incorporated into the SFMA network could be used to tune the final mechanical properties.107

Inorganic nanocarriers made of mesoporous silica nanoparticles (MSNs) have been shown promising properties, such as high surface area, large pore volume, easy potential for physical and chemical functionalization, and overall biocompatibility.109 Furthermore, due to the large mesopores and hollow interior void, hollow mesoporous silica microparticles have the advantage of carrying a large load of model protein and adjuvant and being useful as a carrier of various biomolecules and drugs.110 Ng et al. have developed a photo-cross-linkable microporous aerogel bioink based on methacrylated hollow mesoporous silica microparticles (HMSC-MA) and SFMA (Figure 5E). The scaffold was shown to display a wide range of biophysical and biological properties, including superior mechanical stability and interconnectedness compared to pristine SF scaffolds. A printed scaffold revealed two different ranges of pore sizes, 100–120 μm and 100–1000 μm. A large pore size is a result of voids in structure developed by printing, and a smaller pore size is created by ice replica growth during directional freeze-casting of gel.108 According to the results of Ng et al. study, both SFMA and SFMA-HMSC showed cell viability of greater than 95% during a 7-day of cell culture. A positive impact on cell proliferation, infiltration, and osteoblastic differentiation was also observed in SFMA-HMSCs, making them possible biomaterials for the treatment of bone-related diseases.108 Pang et al. developed a composition containing SFMA and borosilicate (BS) capable of transforming into a SF-MA-BS hydrogel under UV illumination via MA groups modified on both surfaces (i.e., SFMA and methacrylated BS), Figure 5F.32 This composite system can be thoroughly distributed across the entire wound surface and photo-cross-linked in situ to form an integral SF-MA-BS hydrogel.32 They combined BS and SFMA hydrogel with BS weight percentages of 0, 1, 3, and 6 and cross-linked it under UV light (λ = 365 nm) for 15 s.32 The SFMA hydrogel that contained 3% w/v BS had the highest tensile strength when compared with other groups, so they applied this composite system for wound healing.32

Tang et al.93 recently demonstrated the potential for in situ SFMA-based hydrogel and chlorine e6 to enhance wound healing and treatment of cancer. The preparation of SFMA was accomplished by functionalizing SF with MA, as shown in Figure 5G. Additionally, they prepared the SFMA-Ce6 by conjugating the reactive amine of the SFMA to the carboxylic acid functional groups of Chorine e6 (Ce6) using EDC/NHS chemistry. Then, SFMA and SFMA-Ce6 hydrogels were prepared at 7.5 and 10% (w/v) concentrations and their properties, including compressive strength, rheological properties, cytotoxicity, and cell viability were tested. The strength of the SFMA 10% w/v hydrogel is higher than the strength of the SFMA 7.5% w/v, which is 553 and 326 kPa, respectively. The team also evaluated the cytotoxicity of the hydrogel with L929 fibroblasts for 3 days. Both the SFMA and SFMA-Ce6 hydrogels showed higher than 90% cell viability and similar results as the control group. According to their findings, these types of SF based materials have good biocompatibility, over 90%, making them useful in biomedical and wound healing applications. Figure 5G shows that the examined effects of SFMA-Ce6 as a photodynamic therapeutic agent on skin tumors. The hydrogel was placed over the seeded B16F10 melanoma cells on a plate and irradiated under NIR light (20 mW cm–2). The viability of the B16F10 melanoma cells is significantly reduced after 10 min of NIR irradiation in the presence of the SFMA-Ce6. It should be noted, however, that the viability of the cells has increased by more than 95% after 10 min of NIR exposure in the presence of the SFMA, indicating hyperthermic and cancer eradication potential of SFMA-Ce6.

The incorporation of norbornene-functionalized 4-arm poly(ethylene glycol) (PEG4NB) in SFNB can also increase the stiffness of the SFNB-PEGNB hydrogel. Ryu et al. developed the SFNB-PEGNB hydrogel, demonstrating dual mode cross-linking as shown in Figure 5H. The SFNB has been used in composite form with PEGNB and cross-linked based on thiol–ene photoclick chemistry. In this study, PEG4NB was mixed with dithiothreitol (DTT), ∼0.03% LAP, where all components were vortexed for 10 s to produce PEG precursor solutions. In the next step, the solution was exposed to 5 mW/cm2, 365 nm UV light for 2 min. Incorporating 4% of SFNB into 3, 4, and 5% of PEG4NB resulted in hydrogel shear elastic moduli of approximately 1700, 2750, and 3650 Pa as compared to hydrogels without SFNB that had elastic moduli of 625, 1500, and 2600 kPa, respectively.39 Additionally, they observed that SFNB-PEGNB hydrogel stiffness increased over a 5 days period, and the gel modulus remained the same for 2 weeks following the gel preparation. It was also demonstrated that the inclusion of 4% SFNB microgels in PEG-NB hydrogels resulted in a 2-fold increase in shear modulus compared to the modulus on day one after gelation.39

This section comprised discussing selected examples of various materials composited with SFMA or SFNB and how they affected both physicochemical and biological properties of resulting materials. In next section, we will discuss potential for fabricating various structures based on SFMA hydrogels and briefly summarize their uses.

3. Microfabrication and Nanofabrication of SFMA Hydrogels

The growing interest in additive manufacturing and biofabrication technologies has paved the way for the synthesis and chemical modifications of several hydrogel forming biopolymers,111,112 including collagen, gelatin, hyaluronan, SF, chitosan, alginate, pectin, dextran, and PVA. The manufacturing of tissue constructs and ECM mimics is, however, still a challenge.113 The matrices that are built to simulate native ECM should be able to support cell growth and their maintenance, including a mimicking of mechanical and biochemical cues, as well as allow for the efficient nutrient transfer, gas exchange, metabolic waste removal, and cell–cell signaling.113 Multiple state-of-the-art microfabrication technologies have been used to control the three-dimensional microstructure of SFMA hydrogels, which allows further control over cellular interactions and cell behavior. In this section, we present the most prominent selection of micro- and nanoengineered SFMA hydrogels produced by a variety of additive manufacturing techniques, as summarized in Figure 6. While Figure 6A−F depicts the methods we will discuss, Figure 6G shows the length-scales of structures achieved by these methods.

Figure 6.

Figure 6

(A–F) An overview of the micro- and nanofabrication techniques used to fabricate SFMA hydrogel constructs, and (G) resolution and size achieved by each method. Figure created with Biorender.com.

3.1. Micromolded SFMA Hydrogel

Micromolding is one of the most common, simple, and cost-effective methods that can be used for fabricating hydrogel scaffolds with planar and nonplanar surfaces. Using this method, structural attributes such as size, thickness, and pattern can be determined by creating molds.5 Molds may be made of different materials, such as metal or plastic, which are commonly referred to as polytetrafluoroethylene (PTFE) or polydimethylsiloxane (PDMS).114 PDMS is also one of the most commonly used materials for fabricating micromold replicas.115 PDMS has tunable mechanical strength, a transparent optical appearance, and is largely biocompatible, making it ideal for micromolding.115 Furthermore, the surface properties of PDMS molds can be altered in order to alter the fluid wettability of liquids and facilitate the easy removal of hydrogels fabricated from the mold.116 Furthermore, photo-cross-linking combined with micromolding can be used to form patterned hydrogels from prepolymer solutions, as previously explained.5 As described in Barroso’s study, molded hydrogel was fabricated by pouring 200 μL of SFMA hydrogel into a cylindrical mold containing a diameter of 12 mm. Afterward, they were illuminated with UV-A at a light intensity of 3 mW/cm2 for 5 min in order to fully cure to retain shape fidelity.30

3.2. Photopatterned and Shape-Defined SFMA Hydrogels

Since SFMA is a photo-cross-linkable hydrogel, the idea of using a photopatterning technique for the preparation of a hydrogel with a particular topography or for building 3D structures with SFMA-derived hydrogels is appealing. In order to achieve this photopatterning, photomasks can be used, in which the light is irradiated only through the transmittance regions of the photomask and causes a chemical cross-linking to result in spatially confined places resulting in patterned structures. Youn et al. have prepared the micropatterned SFMA/Eumelanin composite films for bioelectronic applications through photopatterning.3638 Furthermore, the lithography technique is one of the advanced methods of fabricating micro- or nano- structures at extremely small scales that allows the creation of precise and complex two-dimensional (2D) or three-dimensional (3D) shapes.117 Pal et al. have developed an SFMA biopolymer which can easily be produced with particles of precise shapes (circles/discs, arrows, squares, triangles, stars) in the range of 5 to 500 μm.36 They found that SFMA particles produced this way are biocompatible and degrade within several weeks (in 1 U protease in PBS/mg of protein settings). It is also possible to control the rate of degradation through the adjustment of particle size, thickness, and cross-linking levels of SFMA proteins. Hence, by varying particle thickness, size, polymer types, and cross-linking levels, the potential release of encapsulated drugs in such SFMA particles can be altered,36 generating future controlled release materials.

3.3. Micropatterned SFMA Hydrogels

One method of micropatterning is to create various surface groove patterns using optically graded glass substrates, followed by the casting of PDMS replica molds. This method, however, has a number of disadvantages, including being hard to scale up and not readily reproducing complex designs due to the need to create transfer molds.118 Xu et al. developed flexible, strong, micropatterned and biodegradable 2D SF based sheets for cellular adhesion and proliferation.118 It was determined that the prepared films are smooth and have patterns ranging between 10 and 25 μm and a pattern height of 500 nm.118 On SFMA patterned film, the human bone marrow–multipotent stromal cells (hBM-MSCs) showed the highest proliferation rate and exhibited clear alignment according to the grid pattern design.118 A further finding was that the cells adhered to the grids of the organization, and it was even more interesting to observe that the cells could migrate between grids and self-assemble into sheets.118 The films can be formed in a variety of thicknesses, ranging from 10 nm to 10 μm thick, with controllable degradability (at 1U protease in PBS/mg of protein).118 The strength of the film was determined to be more than 100 MPa.118 It was possible to roll, bend, or change the conformation of the film numerous times without losing any of its chemical or physical properties.118 By controlling the surface architecture and topography of the flexible sheets, they were able to control the adhesion and spreading of the cultured hBM-MSC cells, showing the potential of this fabrication method for anisotropic tissue constructs.118

3.4. Bioprinting of SFMA Hydrogels/Inks

The development of 3D printing technology has captured significant attention in regenerative medicine and clinical applications due to its ability to produce scaffolds recapitulating more precise and heterogeneous shapes.119 A crucial aspect of this procedure is the development of biocompatible, biodegradable, and printable bioinks. Protein-based hydrogel materials provide an excellent alternative for providing the ECM needed for the encapsulation of cells and the creation of tissues and, indeed, to be used as bioinks. Using the GMA for modification of a SF hydrogel, Kim et al. have developed SF-GMA, which can be used to develop 3D printable bioinks. A biocompatibility study was conducted using NIH/3T3 cells encapsulated in SFMA at different concentrations of 10, 20, and 30%. 10% GelMA was used as a control to compare the biocompatibility of SFMA. In addition, DLP 3D-printing technology was used by Kim et al. for encapsulating the cells without damaging them due to their fast and precise optical printing speeds. On the other hand, they found the swelling behaviors, compressive stress, compressive strain, and compressive elastic modulus at 50% strain, tensile stress, and elongation at break (%) of hydrogel were tuned, and progressively increased, by changing the concentration from 10 to 30%, as shown in Table 3. Based on their results, 30% SFMA resulted in scaffolds that were most easily printed and with best cell growth interactions.

Table 3. Analysis of SFMA-Containing Hydrogels’ Mechanical Propertiesa.

SFMA content (wt %) 10 20 30
compressive stress at break (kPa) 122 ± 45 434 ± 128 910 ± 127
compressive strain at break (%) 69.5 ± 0.5 77.7 ± 3.3 80 ± 5.1
compressive elastic modulus at 50% strain (kPa) 17.7 ± 0.3 47.8 ± 4.8 125.8 ± 34
tensile stress at break (kPa) ND 52 ± 4.3 75 ± 7.5
elongation at break (%) ND 77.6 ± 3.8 124.2 ± 41
tensile elastic modulus at 50% strain (kPa) ND 9.7 ± 1.0 14.5 ± 2.9
water content at 5 h from dried SFMA (%) 4580 ± 480 2026 ± 202 1059 ± 121
expansion rate at 5 h (%) 175.2 ± 6.1 150.0 ± 0.9 145.4 ± 2.4
a

ND indicates no significant difference. The original manuscript used Sil-MA abbreviation, whereas in this paper, we use coherent SFMA abbreviation instead. Reprinted with permission under a Creative Commons CC-BY 4.0 License from ref (24). Copyright 2018 Springer Nature.

3.5. SFMA Hydrogel Fibers and Fabrics

Other techniques to produce complex fibers and scaffolds with highly tunable mechanical properties, combined with an interconnected structure include electrospinning and wet spinning. Since the SFMA stabilization requires a UV illumination system during cross-linking in addition to a fiber spinning system, this poses a technological challenge for the efficient fabrication process. In order to address this issue, the researchers electrospun the SF and then modified their surface by grafting GMA and MA onto the SF. Bae et al. have used the SF solution to electrospin mats that were postfunctionalized using GMA chemistry. Functionalization of the SF with GMA can result in dual cross-linking of the resulting fibrous membrane, including physical cross-linking with ethanol immersion by transformation from a random coil to a β-sheet.34 Further, this fiber can be cross-linked chemically using radical polymerization to improve its water resistance and controlled degradability.34 The total water solubility of fibers in water after dual cross-linking (physical and chemical cross-linking) was much lower, approximately 2%, than that of fibers with only physical cross-linking, approximately 5–7%.34

3.6. SFMA Nanoparticles

In recent years, hydrogel nanoparticles (NPs), often referred to as nanogels, have gained attention for their potential application in drug delivery systems. Additionally, hydrogel nanoparticle materials display both the characteristics and features that hydrogels and nanoparticles individually possess. These particles are ideally suited for pharmaceutical applications because of their hydrophilic, flexible, versatile, highly water absorptive, and biocompatibility properties. A variety of methods have been used to prepare NPs with hydrogel consistency. Many studies have been conducted on a wide range of methods for manufacturing SF NPs, including emulsification,120 salting out,121 supercritical CO2,122 and nanoprecipitation.123 Aside from nanoprecipitation, microfluidic synthesis has also been used to optimize control, reduce waste, and improve quality and consistency. Although the above-mentioned method was used in the preparation of the SF nanoparticles, little research has been conducted on the preparation of SFMA NPs. One method of the preparation of the SFMA NPs is a molecularly imprinted polymer nanoparticle (MIP-NP).29,124 The Bossi group developed imprinted SFMA NPs that assessed binding sites for conjugation into human serum albumin (HSA). To achieve this, 3 nmol of HSA was added to 4 mL of SFMA at concentrations of 0.3 and 0.03 w/v in the presence of 0.2% w/v LAP. They evaluated the size and polydispersity (PDI) of those SFMA NPs after cross-linking by dynamic light scattering (DLS). The size and PDI for two different concentrations of 0.03 and 0.3 w/v% of SFMA solution were 52.8 ± 0.1 (PDI 0.13 ± 0.01) and 94.6 ± 1.3 nm (PDI 0.36 ± 0.02), respectively. As well, they determined that the mean molecular mass of these SFMA NPs for 0.03 and 0.3 w/v % was 7 and 21 MDa, respectively. Furthermore, they used microfibers (raw microfibers after degumming) and electrospun nanofibers to test the performance of MIP SFMA NPs in mat form to make biomedical textiles. This was accomplished by degumming raw cocoons, dissolving them in formic acid, and electrospinning them to produce a nonwoven tissue with fiber dimensions of 300 ± 75 nm. They compared these nanofibers with raw microfibers control group. Afterward, the rhodamine-conjugated MIP NPs were coupled to both SF microfibers, raw microfiber, and also to SF electrospun nanofibers by addition of acryloxyethyl thiocarbamoyl rhodamine B at 0.02% w/v in DMSO. It was found that the raw SF microfibers did not exhibit the endogenous fluorescence they had expected. Furthermore, the fluorescence signals produced by SF nanofibers in contracts are characterized by a specific and homogeneous fluorescence, which indicates that the SF nanofibers have been uniformly functionalized with rhodamine-conjugated SFMA MIP NPs. According to cytotoxicity results, both 0.25 and 1.5 mg/mL SFMA MIP NPs showed less than 15% cell death (similar to control), indicating they are nontoxic and largely biocompatible. Bossi et al. were the first to propose a SFMA as macromolecular monomer for the purpose of the preparation of the stable forming of the nanoparticles for immobilization of the MIP-alb (human serum albumin immobilized MIP).

4. Applications Explored to Date

SFMA hydrogels have been designed and explored for multiple tissue engineering and biomedical applications. In the following sections, we aim to provide the most prominent current state of the art examples of their use, along with links to their physicochemical and structural properties.

4.1. Application in Tissue Engineering and Regenerative Medicine

As can be seen in Figure 7 and from previously described sections, SFMA is a versatile biomaterial with a wide range of adaptable physical and chemical properties, which result in compatibility for a wide variety of applications. In the first instance, we will discuss the general cytotoxicity toward the tissue engineering applications by demonstrating types of cells that have been grown and shown to interact with SFMA. As shown in Table 4, the most common types of studied cells include NIH/3T3, L9292, MEFs, human chondrocytes, and A549.

Figure 7.

Figure 7

SFMA is designed for use in a variety of biomedical applications, including (A) scaffolds. Reprinted with permission from ref (30). Copyright 2021 American Chemical Society. (B) Hemostatic and (C) wound healing agents. Reprinted with permission under Creative Commons CC-BY 4.0 License from ref (33). Copyright 2020 Springer Nature. (D) Injectable hydrogels. Reprinted with permission from ref (93). Copyright 2021 Wiley-VCH GmbH. (E) Cell delivery and (F) bioink for 3D printing of tissues and organs, including cartilage, lungs, brains, skin, and ears. Reprinted with permission under a Creative Commons CC-BY 4.0 License from ref (24). Copyright 2018 Springer Nature. (G) Photoresists. Reprinted with permission from ref (36). Copyright 2016 Elsevier Ltd. (H) Laparoscopic devices. Reprinted with permission under Creative Commons CC-BY 4.0 License from ref (33). Copyright 2020 Springer Nature. (I) Cancer treatments. Adapted with permission from ref (93). Copyright 2021 Wiley-VCH GmbH. Overall figure was created with Biorender.com, with individual elements used with annotated permissions.

Table 4. SF Modified by a Variety of Monomers, Including MA, IEM, GMA, and CA and Their Applications.

grafted monomer degumming approach polymer named cells applications significant observations ref
extraction
MA 0.02 M Na2CO3, 30 min SFMA 3T3 murine fibroblasts bone tissue engineering high cell viability (over 95% in 1st and 4th day) (26)
9.3 M LiBr improved mechanical properties (70 kPa for 5.2% SFMA)
supporting cell growth
tuning the cell behavior with changing hydrogel stiffness and hydrophilicity
MA 0.02 M Na2CO3, 60 °C, 30 min SFMA B16F10 melanoma cells antitumor effects effective photodynamic (93)
9.3 M LiBr, 60 °C, 30 min RAW264.7 cells skin repair antibacterial activity
hair follicle regeneration
IEM 0.02 M Na2CO3, boiling temperature, 30 min FPP murine fibroblast (L-929) cells can be applied in the microelectronics industry and SF-based microdevices simplicity of the production (37)
9.3 M LiBr functionalization of nanomaterials through biotemplating or prototyping tools tuning the mechanical strength and degradation
biological arrays, tissue engineering, and drug delivery being biocompatible
formation of the complex structure with precise shape and size
IEM 0.02 M Na2CO3, 100 °C, 30 min FPP female mouse embryonic fibroblasts (MEFs)  can be used for optics, delivery, or bilocally functional agents monodisperse and precise shapes (36)
9.3 M LiBr controlled release applications fully biodegradable
biocompatible
controlling degradation with carrying size, thickness, and degree of cross-linking of SF proteins
IEM 0.01 M C18H33NaO2 SFMA   various biomedical applications, 3D printing ink, injectable hydrogel, cell culture matrix and surgical glue. good water solubility at various degrees of methacrylation (35)
0.02 + 0.02 M Na2CO3, 60 min quick gelation time (<60 s)
9.3 M LiBr: 0.6 M NaOH, 80 °C high elasticity compared to physically cross-linked SF
GMA 0.05 M Na2CO3, 100 °C, 30 min silk-GMA NIH/3T3 cells cartilage regeneration capability to be used as bioink (73)
9.3 M LiBr, 60 °C, 1 h human chondrocyte 3D DLP printing good mechanical strength
good biocompatibility
GMA NM SF-GMA   scaffold and wound dressing agents dual cross-linking mechanism can be used (34)
CaCl2/EtOH/H2O (1:2:8 M ratio), 70 °C, 1 h high stability for cell attachment, migration, and proliferation
GMA 0.05 M Na2CO3, 100 °C, 30 min SB Neuro2a cells digital light processing (DLP) printable bioink high mechanical strength (>500 kPa) (28)
9.3 M LiBr, 60 °C, 1 h electroconductivity increased by incorporation of GO in SFMA
GMA 0.05 M Na2CO3, 100 °C, 30 min Sil-MAS NIH/3T3 cells in vitro and in vivo hemostatic and wound healing effects sealing without any surgical method (33)
laparoscopic tool in field of robotic surgery excellent adhesive properties with wound closure strength more than 25 kPa
9.3 M LiBr, 60 °C, 1 h versatile medical glue for clinical applications hemostatic effects
high biocompatibility
adequate degradation time (25.1% in vitro degradation in 30 days)
GMA 0.02 M Na2CO3, 100 °C, 1 h Sil-MA primary meniscus cell (pMCs) an attractive alternative to producing fibrocartilaginous tissues. excellent structural integrity and biomechanical performance (27)
9.3 M LiBr, 70 °C, 1 h integrity, with no dimensional changes to fibrocartilaginous tissue
GMA 0.1 M Na2CO3, 100 °C, 30 min SF-g-GMA   meniscus tissue engineering effect of the CaCl2 concentrations and ratio of the SF to the CaCl2 on SF solubility (125)
effect of the dialysis time on efficiency of the salt removing
3.6, 4.5, and 5.4 M CaCl2, 70 °C, 6 h effect of the SF to GMA molar ratio on grafting process and amounts
GMA 0.05 M Na2CO3 100 °C, 1 h silk-GMA NIH/3T3 cells mouse embryonic fibroblast cell line hydrogel with potential to be applied in clinical transplantation for tissue engineering and biomedical applications effect of dialysis period on the β-sheet contents of SF and cell proliferation and viability rate (live–dead assays showed 66% and 97% cell viability for hydrogels with 0 and 7 days of dialysis) (60)
9.3 M LiBr, 60 °C, 1 h
GMA 0.02 M Na2CO3, 100 °C 30 min silkMA human dermal fibroblasts (HDFs) tissue engineering applications the effect of the pH on the rheology of the hydrogel, mechanical strength, swelling behavior, cell proliferation and attachments; the SFMA with pH 8 shows more than twice hydrogel expansion (34.4%) and swelling ratio (86%), compared with SFMA with pH 5 (30)
9.3 M LiBr, 60 °C, 1 h the compressive modulus of SFMA at pH 5 is twice as high (40 kPa) as SFMA at pH 7
cell viability of more than 90%
GMA 1st bath: 0.01 M Na2CO3 100 °C, 1 h SF-MA NIH 3T3 can be used as biomaterials with extra functionalities nontoxic (29)
2nd bath: 0.001 M Na2CO3, 100 °C, 1 h biocompatible (more than 80% cell viability)
9.3 M LiBr, 4 h, 65 °C
GMA 0.02 M Na2CO3, 100 °C, 1 h Sil-MA NIH 3T3 Ink to build complex organ structures, including the heart, vessel, brain, trachea and ear tuning the mechanical strength with varying the SFMA content (compressive stress at break of around 910 kPa for 30% SFMA) (24)
chondrocytes were isolated from human septal cartilage outstanding mechanical and rheological properties
9.3 M LiBr, 60 °C, 1 h excellent structural ability
reliable biocompatibility
CA 0.03 M C18H33NaO2 SF-NB mouse embryonic fibroblasts (NIH/3T3) three-dimensional cell culture requiring temporal control of hydrogel stiffness controllable cross-linking based on two mechanisms including thiol–ene and photoclick reaction. (39)
0.04 + 0.02 M Na2CO3 60 min   cell encapsulation elastic moduli of 1.5–3 kPa depend on the SFNB contents (0–4 wt %)
9.3 M LiBr 60 °C, 1 h adenocarcinoma human alveolar basal epithelial cells (A549) tumor development and tissue fibrosis model
CA 0.05 M Na2CO3, 100 °C, 40 min RFS-NB mouse fibroblast (L929) cells 3D printed scaffolds for tissue engineering good biocompatibility (>95%) (40)
9.3 M LiBr, 40 °C, 40 min mechanical strength depends on the UV exposure time (by increasing the UV exposure time from 1 to 10, the ultimate storage modulus increases from 51 to 1700 Pa)

Recent reports have demonstrated that SFMA hydrogels can be effectively used as an active matrix material in both 2D30 and 3D24 cell culture experiments. To form cell-laden 3D hydrogels, it is possible to suspend cells in SFMA prepolymer solutions and cross-link them upon exposure to UV light. According to Kim et al., NIH/3T3 cell viability and proliferation in SFMA hydrogels changed as a function of the UV cross-linking time. The samples were exposed to UV for 10, 20, and 30 s, and it was found that the samples with longer irradiation times (20 and 30 s) demonstrated a higher cell proliferation ratio than those with lower levels of irradiation or pristine SF.33

Barroso et al. evaluated the cell attachment and proliferation with direct seeding of human dermal fibroblasts (HDF) cells on different types of SFMA (prepared at three different pH values of 5, 7, and 8) and compared it to the GelMA hydrogel, which due to its extensive studies and use in cell culture applications constitutes a benchmark. Based on these results, it appears that SFMA hydrogels are capable of supporting HDF cell attachment and proliferation; however, the cells deposited in SFMA hydrogels showed relatively little spreading compared to the GelMA hydrogels. These reasons may be attributed to the lack of adhesive amino acid sequences (e.g., RGD) in the SF composition. Although, the results show that after the cells had been grown for 7 days, they exhibited typical fibroblastic morphology and reached confluence, similarly to the results observed on GelMA hydrogels.30

As previously mentioned, an elastic hybrid construct for advanced fibrocartilaginous tissue regeneration using GG/FB composite bioinks in conjunction with SFMA bioink hydrogels was developed by Costa et al.27 This formulation of SFMA 16% (w/v) contained gelatin and glycerol with concentrations of 4.5% (w/v) and 8 (w/v) %, respectively. A GG/FB bioink contains GG with a fixed concentration of 12 mg/mL and FB with concentrations ranging from 1, 2, 3, 4, 5, and 6 mg/mL. Compared to other concentrations, the GG/FB4 was considered the best GG/FB bioink in vitro and in vivo. In this study, a 3D integrated tissue-organ printing system was used for the 3D printing of the constructs. Furthermore, the bioinks GG/FB and SFMA were printed under two different conditions. GG/FB bioinks were printed using a nozzle with a diameter of 240 μm, at velocity of 250 mm/min, and air pressures between 45 and 65 kPa. Following 3D printing, the constructs were cross-linked with thrombin solution (20 U/mL) for 30 min. In contrast, SFMA bioinks were printed at 250 mm/min, with 300 μm diameter nozzle, and with 450 to 550 kPa air pressure.27 Their results showed that the SFMA bioinks offered biomechanical properties and structural integrity, while the GG/FB bioink offers a microenvironment that ensures the maintenance of cell viability and proliferation.27

Using a standard digital lighting processing (DLP) printer, Hong et al. encapsulated and printed the NIH/3T3 mouse fibroblast cells and human chondrocytes in SFMA bioink hydrogel for cartilage tissue engineering. As part of their study, they evaluated the chondrogenesis of human chondrocyte-laden SFMA in vitro and then applied it in vivo. The authors ensured even cell distribution in printed SFMA hydrogels due to the rapid printing speed and photopolymerization in DLP method utilized here. The contents of glycosaminoglycan (GAG) in human chondrocytes-laden SFMA were evaluated after cultivation for 1, 2, and 4 weeks to determine whether in vitro chondrogenic regeneration had occurred. While the amount of GAG did not change significantly over the first week, after 4 weeks, it had remarkably increased, about three times the amount in the first week. They also examined the expression of cartilage specific genes such as collagen type II, collagen X, SOX-9, and aggrecan in cultured 3D chondrocyte cells laden-SFMA using reverse transcription-polymerase chain reaction (RT-PCR) and gel electrophoresis. During the first and second week of culture, the collagen type II, collagen X, SOX-9, and aggrecan genes were not expressed. After 4 weeks of cultivation, these genes were expressed, indicating SFMA bioink containing chondrocyte cells could lead to generation of functional cartilage with SFMA.73

4.2. Other Therapeutic Applications

In situ formed hydrogel offers inherent advantages for a wide range of biomedical applications such as oncology, drug delivery, and tissue reconstruction. The input factors of local microenvironments (temperature, pH, enzymes, etc.) or external factors (light) enable injectable precursor solutions to directly fill irregular defects. The studies confirmed that the SF-based hydrogel had been found to be biocompatible in biomedical applications without causing any long-term inflammatory reactions.14 Additionally, the research done previously indicates that SF offers hemostasis, which is very beneficial to wound healing progress.126,33 In addition, it promotes the recruitment of various types of cells, such as neutrophils, macrophages, endothelial cells, fibroblasts, and keratinocytes, and facilitates the proliferation of skin fibroblasts.93

As previously mentioned, Tang et al. have demonstrated the potential of using hydrogels derived from SFMA and chlorine e693 to enhance wound healing and cancer treatment. Following previously described successful in vitro study (see section 2.3), the authors have further evaluated the efficacy of SFMA-Ce6 hydrogel in vivo. This was accomplished by creating 5 mm wounds at tumor sites on BALB/c nude mice bearing B16F10 tumors. The authors assessed the therapeutic effects of in vivo photodynamic therapy by covering tissues with saline (control), SFMA (SFMA-20), or SFMA-Ce6 hydrogel and exposing them to NIR (660 nm, 20 mW cm–2) light for 10 min. After photodynamic therapy, tumor volumes in the SFMA-Ce6 group were significantly lower than those in the saline or SFMA groups, and wound closure was better in SFMA-Ce6 mice than in the other groups. It can be concluded that this silk-based hydrogel system, as a wound dressing that is multifunctional, paves the way for new techniques of tumor therapy and skin regeneration for humans.93

Surgical sealants are designed to prevent gas leakage or nonclotting fluids from the injured tissues and blood from the vascular supply after surgery or injury.127 A surgical sealant has also been made with SFMA hydrogels as another exemplar application of this material. Kim et al. propose that SFMA could be a suitable photocuring medical glue used to improve laparoscopic surgery.33 As part of the preparation of the SFMA, GMA was used to functionalize SF. A 25% (w/v) concentration of SFMA hydrogels was prepared and tested for their properties, including compression strength, tensile strength, rheological properties and adhesive properties. Kim et al. compared SFMA 25% to the commercial liquid bandage and active sealant Medifoam (MLB, Mundipharma). It was observed that the shear strain and shear stress at the break of SFMA were higher than those of MLB. Further, the adhesive strength of SFMA was strong enough to hold and lift a wrench (0.9 kg). Furthermore, to investigate the wound closure properties of the SFMA, the researchers made skin incisions 1.5 cm long on the backs of the rats. After applying 200 μL of SFMA onto the wound, they exposed it to UV light for 10 s in order to cross-link it, as shown in Figure 8A. In comparison to gauze, SFMA, and Avitene (commercial artificial dermis Avitene), the SFMA treatment showed a lower wound area and a better wound closure (Figure 8B). Moreover, they also tested SFMA sealant properties on an animal model of femoral artery hemorrhage. This experiment involved the creation of an incision in the femoral vein and artery using a sterilized scalpel. The injured area was gently covered with gauze for 3 s following the initial 5 s of bleeding. Subsequently, 50 μL of SFMA were applied to the area and exposed to UV light for 20 s, Figure 8B. Additionally, they examined the biocompatibility and degradation of the SFMA in vitro via the CCK-8 assay and in vivo using subcutaneous hydrogel implants.33 They also exposed the SFMA to UV radiation for 10, 20, and 30 s, and then compared it with SF (pristine). According to the CCK-8 results, there was no significant difference in cell viability between SF and SFMA with different exposure times on day 0. It should be noted that after 3 days of cultivation, the sealant that was exposed for longer times, 20 and 30 s, had a greater level of viability than the sealant which was exposed for shorter times (10 s). In the long term, SFMA increased the number of vascular structures and collagenous tissue while decreasing the number of infiltrating macrophages, reflecting its biocompatibility. Based on the in vivo, SFMA has proven to be effective at providing secure and long-lasting sealing due to its excellent adhesive properties, hemostatic properties, and wound healing properties.126,33 The SFMA also demonstrated good biocompatibility and long-term degradation, so it was not necessary to retreat or remove it from the injury site.33

Figure 8.

Figure 8

Illustration of (A) the hemostasis measurement on a skin defect in a rat (1 cm (w) × 1 cm (d) × 0.3 cm (h)), wound closure test with skin incisions, 1.5 cm length, in vivo vascular closure test, in vivo rat liver parenchymal injury model, using SFMA. (B) The wound area after dressing treatment with SFMA, along with a Western blot analysis of VEGF, fibronectin, vimentin, cyclin D1, and β-actin shows the strongest expression at day 3, and (C) laparoscopic surgical procedure images of a liver laceration model with a homemade SFMA device and a three-pot laparoscopic field. (D) (a–c) Create deep and superficial liver lacerations with endoscopic scissors and suction, (d) apply gauze, (e) administer 1 mL SFMA by using a homemade laparoscopic SFMA device, (f) expose to UV light (20 s) via fiber optic lens, (g) monitor for blood leakage or rebleeding with endoscopic forceps, and (h) ensure the SFMA adheres to the liver laceration. The original manuscript used Sil-MA abbreviation, whereas in this paper, we use coherent SFMA abbreviation instead. Reprinted with permission under a Creative Commons CC-BY 4.0 License from ref (24). Copyright 2018 Springer Nature.

Based on the results of Kim et al., it appears that SFMA can be used as photocuring medical glue during laparoscopic surgery. They developed an endoscopic device composed of SFMA and a light source, which is used for laparoscopic surgery (Figure 8C). As shown in Figure 8D, the laparoscopic surgical device was used to administer the SFMA, and the UV treatment led to successful gelation, adhesion, and hemocoagulation of the liver tissue.33 Hence, SFMA is a viable option to enhance the efficiency of laparoscopic procedures, proving itself as potential translational surgical glue.

5. Conclusions and Future Perspectives

SF exhibits a number of characteristics that distinguish it from other materials, including its biocompatibility, biodegradability, nontoxic nature, mechanical strength, and ease of acquisition.128 Despite the fact that SF is soft in nature, its potential applications are limited by this characteristic.128 By introducing functional groups such as methacryloyl and norbornene, the cross-linkable sites on the SF are created. Here we discussed several approaches to achieving these in SF, including influence of its original sources and roadmap from degumming and extraction, to final modification with methacrylate and norbornene. Moreover, we described different approaches to methacrylating silk fibroin using different methacrylation reagents, including methacrylic anhydride (MA), 2-isocyanatoethyl methacrylate (IEM), or glycidyl methacrylate (GMA) and norbornene groups. We highlight that SFMA and SFNB hydrogel storage moduli may differ depending on the SF source, the degree of modification with functional photo-cross-linked group, and the initiator concentration, as well as the UV intensity and other environmental factors including pH or type of used solvent.

SFMA’s and SFNB’s photo-cross-linkable biomaterials have been additively manufactured using microfabrication methods, including photopatterning,36 micromolding,30 and DLP bioprinting,27,28,24 which can also be employed for encapsulating cells in situ in hydrogel with a defined 3D structure and topology. Although some fabrication techniques have been used, we highlight that to our knowledge the extrusion-based printing of SFMA-based materials has not been efficiently achieved or reported.

Finally, we summarized the SFMA and SFNB-based bioinks and their composites in terms of their potential for the use in regenerative medicine and tissue engineering. We anticipate that new microfabrication techniques such as microfluidics and wet-spinning will enable SFMA-based materials to be used in a wider range of applications, e.g. in form of the microcapsules and microfibers, in the next few years. Nevertheless, there are still a number of improvements that must be made in the formulations and characterization of inks in order to make in situ 3D printing a reliable process.43 It is crucial to standardize SF extraction protocols, examine exact in vivo degradation mechanisms, and set sterilization protocols compatible with clinical conditions.43 SF sequences can be easily chemically modified, which may play a crucial role in possibilities of using them as controlled materials or for the binding of specific biomolecules to them. It is important to note, however, that the extracted SF solution is stable only at a specific pH and temperature ranges.129 Consequently, it is important to take this point into consideration when binding growth factors or enzymes to SF-based biomaterials, or when using these in vivo.

Given so far the established properties of SFMA, it certainly carries the potential to be used as a cargo vehicle for the delivery of bioactive agents, such as anticancer drugs, anti-inflammatory drugs, or growth factors, and numerous chemical groups on it will enable an environment of controlling the release properties by tuning of molecular interactions, as is the case for other peptides or protein-based materials.130 Moreover, this photo-cross-linkable SF-based hydrogel has the potential to be developed into a functional biomaterial that is capable of sealing (and even healing) surgical injuries, which could lead to the development of biomaterials that in future release oxygen in the wound during healing process. Thus, various formulations of SF-based bioinks need to be evaluated, characterized, and standardized in order to prevent all potential in vivo cytotoxic effects of the photoinitiators. Further, a number of improvements must still be made before in situ systems can be developed to address tissues mechanical, cellular, vascular, and innervation requirements.

Acknowledgments

Authors acknowledge funding from the European Union’s Horizon 2020 research and innovation programme under the Grant Agreement No. 857287 (BBCE). J.K.W. acknowledges European Union’s Horizon 2020 (H2020-MSCA-IF-2019) Research and Innovation Programme under the Marie Skłodowska-Curie Grant Agreement 893099 – ImmunoBioInks.

The authors declare no competing financial interest.

References

  1. Amirian J.; Zeng Y.; Shekh M. I.; Sharma G.; Stadler F. J.; Song J.; Du B.; Zhu Y. In-situ crosslinked hydrogel based on amidated pectin/oxidized chitosan as potential wound dressing for skin repairing. Carbohydr. Polym. 2021, 251, 117005. 10.1016/j.carbpol.2020.117005. [DOI] [PubMed] [Google Scholar]
  2. Amirian J.; Linh N. T. B.; Min Y. K.; Lee B.-T. Bone formation of a porous Gelatin-Pectin-biphasic calcium phosphate composite in presence of BMP-2 and VEGF. Int. J. Biol. Macromol. 2015, 76, 10–24. 10.1016/j.ijbiomac.2015.02.021. [DOI] [PubMed] [Google Scholar]
  3. Bandyopadhyay A.; Mandal B. B.; Bhardwaj N. 3D bioprinting of photo-crosslinkable silk methacrylate (SilMA)-polyethylene glycol diacrylate (PEGDA) bioink for cartilage tissue engineering. J. Biomed. Mater. Res., Part A 2022, 110 (4), 884–898. 10.1002/jbm.a.37336. [DOI] [PubMed] [Google Scholar]
  4. a Salma-Ancane K.; Sceglovs A.; Tracuma E.; Wychowaniec J. K.; Aunina K.; Ramata-Stunda A.; Nikolajeva V.; Loca D. Effect of crosslinking strategy on the biological, antibacterial and physicochemical performance of hyaluronic acid and ε-polylysine based hydrogels. Int. J. Biol. Macromol. 2022, 208, 995–1008. 10.1016/j.ijbiomac.2022.03.207. [DOI] [PubMed] [Google Scholar]; b Walsh C. M.; Wychowaniec J. K.; Brougham D. F.; Dooley D. Functional hydrogels as therapeutic tools for spinal cord injury: New perspectives on immunopharmacological interventions. Pharmacol. Ther. 2022, 234, 108043. 10.1016/j.pharmthera.2021.108043. [DOI] [PubMed] [Google Scholar]
  5. Yue K.; Trujillo-de Santiago G.; Alvarez M. M.; Tamayol A.; Annabi N.; Khademhosseini A. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials 2015, 73, 254–271. 10.1016/j.biomaterials.2015.08.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Amirian J.; Van T. T. T.; Bae S.-H.; Jung H.-I.; Choi H.-J.; Cho H.-D.; Lee B.-T. Examination of In vitro and In vivo biocompatibility of alginate-hyaluronic acid microbeads As a promising method in cell delivery for kidney regeneration. Int. J. Biol. Macromol. 2017, 105, 143–153. 10.1016/j.ijbiomac.2017.07.019. [DOI] [PubMed] [Google Scholar]
  7. a Treacy N. J.; Clerkin S.; Davis J. L.; Kennedy C.; Miller A. F.; Saiani A.; Wychowaniec J. K.; Brougham D. F.; Crean J. Growth and differentiation of human induced pluripotent stem cell (hiPSC)-derived kidney organoids using fully synthetic peptide hydrogels. Bioact. Mater. 2023, 21, 142–156. 10.1016/j.bioactmat.2022.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Elsawy M. A.; Wychowaniec J. K.; Castillo Díaz L. A.; Smith A. M.; Miller A. F.; Saiani A. Controlling Doxorubicin Release from a Peptide Hydrogel through Fine-Tuning of Drug–Peptide Fiber Interactions. Biomacromolecules 2022, 23 (6), 2624–2634. 10.1021/acs.biomac.2c00356. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Singh Y. P.; Bandyopadhyay A.; Mandal B. B. 3D Bioprinting Using Cross-Linker-Free Silk–Gelatin Bioink for Cartilage Tissue Engineering. ACS Appl. Mater. Interfaces 2019, 11 (37), 33684–33696. 10.1021/acsami.9b11644. [DOI] [PubMed] [Google Scholar]
  8. Choi J. R.; Yong K. W.; Choi J. Y.; Cowie A. C. Recent advances in photo-crosslinkable hydrogels for biomedical applications. BioTechniques 2019, 66 (1), 40–53. 10.2144/btn-2018-0083. [DOI] [PubMed] [Google Scholar]
  9. Vashist A.; Vashist A.; Gupta Y. K.; Ahmad S. Recent advances in hydrogel based drug delivery systems for the human body. J. Mater. Chem. B 2014, 2 (2), 147–166. 10.1039/C3TB21016B. [DOI] [PubMed] [Google Scholar]
  10. Vashist A.; Kaushik A.; Alexis K.; Dev Jayant R.; Sagar V.; Vashist A.; Nair M. Bioresponsive Injectable Hydrogels for On-demand Drug Release and Tissue Engineering. Curr. Pharm. Des. 2017, 23 (24), 3595–3602. 10.2174/1381612823666170516144914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Amirian J.; Linh N. T. B.; Min Y. K.; Lee B.-T. The effect of BMP-2 and VEGF loading of gelatin-pectin-BCP scaffolds to enhance osteoblast proliferation. J. Appl. Polym. Sci. 2015, 132 (2), 4124. 10.1002/app.41241. [DOI] [Google Scholar]
  12. Amirian J.; Abdi G.; Shekh M. I.; Zendehdel E. A.; Du B.; Stadler F. J. Gelatin Based Hydrogels for Tissue Engineering and Drug Delivery Applications. Materials Research Foundations 2021, 87, 244–270. 10.21741/9781644901076-10. [DOI] [Google Scholar]
  13. a Karimi F.; Lau K.; Kim H. N.; Och Z.; Lim K. S.; Whitelock J.; Lord M.; Rnjak-Kovacina J. Surface Biofunctionalization of Silk Biomaterials Using Dityrosine Cross-Linking. ACS Appl. Mater. Interfaces 2022, 14 (28), 31551–31566. 10.1021/acsami.2c03345. [DOI] [PubMed] [Google Scholar]; b Zhao Z.; Li Y.; Xie M. B. Silk fibroin-based nanoparticles for drug delivery. Int. J. Mol. Sci. 2015, 16 (3), 4880–4903. 10.3390/ijms16034880. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Ribeiro V. P.; Costa J. B.; Carneiro S. M.; Pina S.; Veloso A. C. A.; Reis R. L.; Oliveira J. M. Bioinspired Silk Fibroin-Based Composite Grafts as Bone Tunnel Fillers for Anterior Cruciate Ligament Reconstruction. Pharmaceutics 2022, 14, 697. 10.3390/pharmaceutics14040697. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Durán-Rey D.; Brito-Pereira R.; Ribeiro C.; Ribeiro S.; Sánchez-Margallo J. A.; Crisóstomo V.; Irastorza I.; Silván U.; Lanceros-Méndez S.; Sánchez-Margallo F. M. Development of Silk Fibroin Scaffolds for Vascular Repair. Biomacromolecules 2023, 24 (3), 1121–1130. 10.1021/acs.biomac.2c01124. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Dickerson M. B.; Fillery S. P.; Koerner H.; Singh K. M.; Martinick K.; Drummy L. F.; Durstock M. F.; Vaia R. A.; Omenetto F. G.; Kaplan D. L.; et al. Dielectric Breakdown Strength of Regenerated Silk Fibroin Films as a Function of Protein Conformation. Biomacromolecules 2013, 14 (10), 3509–3514. 10.1021/bm4008452. [DOI] [PubMed] [Google Scholar]
  14. Sapudom J.; Kongsema M.; Methachittipan A.; Damrongsakkul S.; Kanokpanont S.; Teo J. C. M.; Khongkow M.; Tonsomboon K.; Thongnuek P. Degradation products of crosslinked silk fibroin scaffolds modulate the immune response but not cell toxicity. J. Mater. Chem. B 2023, 11 (16), 3607–3616. 10.1039/D3TB00097D. [DOI] [PubMed] [Google Scholar]
  15. a Mohammadzadehmoghadam S.; Dong Y.. Electrospinning of silk fibroin-based nanofibers and their applications in tissue engineering. In Electrospun Polymers and Composites; Dong Y., Baji A., Ramakrishna S., Eds.; Woodhead Publishing, 2021; Chapter 4, pp 111–146. [Google Scholar]; b Alessandrino A.; Marelli B.; Arosio C.; Fare S.; Tanzi M. C.; Freddi G. Electrospun Silk Fibroin Mats for Tissue Engineering. Eng. Life Sci. 2008, 8 (3), 219–225. 10.1002/elsc.200700067. [DOI] [Google Scholar]; c Llano E.; Ríos D.; Restrepo G. Evaluation of Technologies for Stabilization of Road Soils Using Accelerated Weathering. A Strategy for Analysis of Impacts on Biodiversity. TecnoLógicas 2020, 23 (49), 185–199. 10.22430/22565337.1624. [DOI] [Google Scholar]
  16. Shefa A. A.; Amirian J.; Kang H. J.; Bae S. H.; Jung H.-I.; Choi H.-j.; Lee S. Y.; Lee B.-T. In vitro and in vivo evaluation of effectiveness of a novel TEMPO-oxidized cellulose nanofiber-silk fibroin scaffold in wound healing. Carbohydr. Polym. 2017, 177, 284–296. 10.1016/j.carbpol.2017.08.130. [DOI] [PubMed] [Google Scholar]
  17. a Melke J.; Midha S.; Ghosh S.; Ito K.; Hofmann S. Silk fibroin as biomaterial for bone tissue engineering. Acta Biomater. 2016, 31, 1–16. 10.1016/j.actbio.2015.09.005. [DOI] [PubMed] [Google Scholar]; b Li Y.; Liu Z.; Tang Y.; Fan Q.; Feng W.; Luo C.; Dai G.; Ge Z.; Zhang J.; Zou G.; et al. Three-dimensional silk fibroin scaffolds enhance the bone formation and angiogenic differentiation of human amniotic mesenchymal stem cells: a biocompatibility analysis. Acta Biochim. Biophys. Sin. 2020, 52 (6), 590–602. 10.1093/abbs/gmaa042. [DOI] [PubMed] [Google Scholar]; c Deshpande R.; Shukla S.; Kale A.; Deshmukh N.; Nisal A.; Venugopalan P. Silk Fibroin Microparticle Scaffold for Use in Bone Void Filling: Safety and Efficacy Studies. ACS Biomater. Sci. Eng. 2022, 8 (3), 1226–1238. 10.1021/acsbiomaterials.1c01103. [DOI] [PubMed] [Google Scholar]
  18. a Farokhi M.; Mottaghitalab F.; Fatahi Y.; Saeb M. R.; Zarrintaj P.; Kundu S. C.; Khademhosseini A. Silk fibroin scaffolds for common cartilage injuries: Possibilities for future clinical applications. Eur. Polym. J. 2019, 115, 251–267. 10.1016/j.eurpolymj.2019.03.035. [DOI] [Google Scholar]; b Yuan T.; Li Z.; Zhang Y.; Shen K.; Zhang X.; Xie R.; Liu F.; Fan W. Injectable Ultrasonication-Induced Silk Fibroin Hydrogel for Cartilage Repair and Regeneration. Tissue Eng., Part A 2021, 27 (17–18), 1213–1224. 10.1089/ten.tea.2020.0323. [DOI] [PubMed] [Google Scholar]; c Cheng G.; Davoudi Z.; Xing X.; Yu X.; Cheng X.; Li Z.; Deng H.; Wang Q. Advanced Silk Fibroin Biomaterials for Cartilage Regeneration. ACS Biomater. Sci. Eng. 2018, 4 (8), 2704–2715. 10.1021/acsbiomaterials.8b00150. [DOI] [PubMed] [Google Scholar]
  19. a Yu R.; Yang Y.; He J.; Li M.; Guo B. Novel supramolecular self-healing silk fibroin-based hydrogel via host–guest interaction as wound dressing to enhance wound healing. Chem. Eng. J. (Amsterdam, Neth.) 2021, 417, 128278. 10.1016/j.cej.2020.128278. [DOI] [Google Scholar]; b Vidya M.; Rajagopal S. Silk Fibroin: A Promising Tool for Wound Healing and Skin Regeneration. Int. J. Polym. Sci. 2021, 2021, 1. 10.1155/2021/9069924. [DOI] [Google Scholar]
  20. a Biswas S.; Bhunia B. K.; Janani G.; Mandal B. B. Silk Fibroin Based Formulations as Potential Hemostatic Agents. ACS Biomater. Sci. Eng. 2022, 8 (6), 2654–2663. 10.1021/acsbiomaterials.2c00170. [DOI] [PubMed] [Google Scholar]; b Sultan M. T.; Hong H.; Lee O. J.; Ajiteru O.; Lee Y. J.; Lee J. S.; Lee H.; Kim S. H.; Park C. H. Silk Fibroin-Based Biomaterials for Hemostatic Applications. Biomolecules 2022, 12 (5), 660. 10.3390/biom12050660. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Huang L.; Yuan W.; Hong Y.; Fan S.; Yao X.; Ren T.; Song L.; Yang G.; Zhang Y. 3D printed hydrogels with oxidized cellulose nanofibers and silk fibroin for the proliferation of lung epithelial stem cells. Cellulose 2021, 28 (1), 241–257. 10.1007/s10570-020-03526-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ling S.; Qin Z.; Li C.; Huang W.; Kaplan D. L.; Buehler M. J. Polymorphic regenerated silk fibers assembled through bioinspired spinning. Nat. Commun. 2017, 8 (1), 1387. 10.1038/s41467-017-00613-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. a Nultsch K.; Bast L. K.; Näf M.; Yakhlifi S. E.; Bruns N.; Germershaus O. Effects of Silk Degumming Process on Physicochemical, Tensile, and Optical Properties of Regenerated Silk Fibroin. Macromol. Mater. Eng. 2018, 303 (12), 1800408. 10.1002/mame.201800408. [DOI] [Google Scholar]; b Ho M.-p.; Wang H.; Lau K.-t. Effect of degumming time on silkworm silk fibre for biodegradable polymer composites. Appl. Surf. Sci. 2012, 258 (8), 3948–3955. 10.1016/j.apsusc.2011.12.068. [DOI] [Google Scholar]; c Li M.; Tian W.; Zhang Y.; Song H.; Yu Y.; Chen X.; Yong N.; Li X.; Yin Y.; Fan Q.; et al. Enhanced Silk Fibroin/Sericin Composite Film: Preparation, Mechanical Properties and Mineralization Activity. Polymers 2022, 14 (12), 2466. 10.3390/polym14122466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. a Wang Q.; Han G.; Yan S.; Zhang Q. 3D Printing of Silk Fibroin for Biomedical Applications. Materials 2019, 12 (3), 504. 10.3390/ma12030504. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Tan X. H.; Liu L.; Mitryashkin A.; Wang Y.; Goh J. C. H. Silk Fibroin as a Bioink – A Thematic Review of Functionalization Strategies for Bioprinting Applications. ACS Biomater. Sci. Eng. 2022, 8 (8), 3242–3270. 10.1021/acsbiomaterials.2c00313. [DOI] [PubMed] [Google Scholar]
  24. Kim S. H.; Yeon Y. K.; Lee J. M.; Chao J. R.; Lee Y. J.; Seo Y. B.; Sultan M. T.; Lee O. J.; Lee J. S.; Yoon S.-i.; et al. Precisely printable and biocompatible silk fibroin bioink for digital light processing 3D printing. Nat. Commun. 2018, 9 (1), 1620. 10.1038/s41467-018-03759-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Trucco D.; Sharma A.; Manferdini C.; Gabusi E.; Petretta M.; Desando G.; Ricotti L.; Chakraborty J.; Ghosh S.; Lisignoli G. Modeling and Fabrication of Silk Fibroin–Gelatin-Based Constructs Using Extrusion-Based Three-Dimensional Bioprinting. ACS Biomater. Sci. Eng. 2021, 7 (7), 3306–3320. 10.1021/acsbiomaterials.1c00410. [DOI] [PubMed] [Google Scholar]
  26. Bessonov I. V.; Rochev Y. A.; Arkhipova Y.; Kopitsyna M. N.; Bagrov D. V.; Karpushkin E. A.; Bibikova T. N.; Moysenovich A. M.; Soldatenko A. S.; Nikishin I. I.; et al. Fabrication of hydrogel scaffolds via photocrosslinking of methacrylated silk fibroin. Biomed. Nanomater. 2019, 14 (3), 034102. 10.1088/1748-605X/ab04e0. [DOI] [PubMed] [Google Scholar]
  27. Costa J. B.; Park J.; Jorgensen A. M.; Silva-Correia J.; Reis R. L.; Oliveira J. M.; Atala A.; Yoo J. J.; Lee S. J. 3D Bioprinted Highly Elastic Hybrid Constructs for Advanced Fibrocartilaginous Tissue Regeneration. Chem. Mater. 2020, 32 (19), 8733–8746. 10.1021/acs.chemmater.0c03556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ajiteru O.; Sultan M. T.; Lee Y. J.; Seo Y. B.; Hong H.; Lee J. S.; Lee H.; Suh Y. J.; Ju H. W.; Lee O. J.; et al. A 3D Printable Electroconductive Biocomposite Bioink Based on Silk Fibroin-Conjugated Graphene Oxide. Nano Lett. 2020, 20 (9), 6873–6883. 10.1021/acs.nanolett.0c02986. [DOI] [PubMed] [Google Scholar]
  29. Bossi A. M.; Bucciarelli A.; Maniglio D. Molecularly Imprinted Silk Fibroin Nanoparticles. ACS Appl. Mater. Interfaces 2021, 13 (27), 31431–31439. 10.1021/acsami.1c05405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Barroso I. A.; Man K.; Villapun V. M.; Cox S. C.; Ghag A. K. Methacrylated Silk Fibroin Hydrogels: pH as a Tool to Control Functionality. ACS Biomater. Sci. Eng. 2021, 7 (10), 4779–4791. 10.1021/acsbiomaterials.1c00791. [DOI] [PubMed] [Google Scholar]
  31. Bucciarelli A.; Muthukumar T.; Kim J. S.; Kim W. K.; Quaranta A.; Maniglio D.; Khang G.; Motta A. Preparation and Statistical Characterization of Tunable Porous Sponge Scaffolds using UV Cross-linking of Methacrylate-Modified Silk Fibroin. ACS Biomater. Sci. Eng. 2019, 5 (12), 6374–6388. 10.1021/acsbiomaterials.9b00814. [DOI] [PubMed] [Google Scholar]
  32. Pang L.; Tian P.; Cui X.; Wu X.; Zhao X.; Wang H.; Wang D.; Pan H. In Situ Photo-Cross-Linking Hydrogel Accelerates Diabetic Wound Healing through Restored Hypoxia-Inducible Factor 1-Alpha Pathway and Regulated Inflammation. ACS Appl. Mater. Interfaces 2021, 13 (25), 29363–29379. 10.1021/acsami.1c07103. [DOI] [PubMed] [Google Scholar]
  33. Kim S. H.; Lee Y. J.; Chao J. R.; Kim D. Y.; Sultan M. T.; Lee H. J.; Lee J. M.; Lee J. S.; Lee O. J.; Hong H.; et al. Rapidly photocurable silk fibroin sealant for clinical applications. NPG Asia Mater. 2020, 12 (1), 46. 10.1038/s41427-020-0227-6. [DOI] [Google Scholar]
  34. Bae S. B.; Kim M. H.; Park W. H. Electrospinning and dual crosslinking of water-soluble silk fibroin modified with glycidyl methacrylate. Polym. Degrad. Stab. 2020, 179, 109304. 10.1016/j.polymdegradstab.2020.109304. [DOI] [Google Scholar]
  35. Kim H. H.; Kim J. W.; Choi J.; Park Y. H.; Ki C. S. Characterization of silk hydrogel formed with hydrolyzed silk fibroin-methacrylate via photopolymerization. Polymer 2018, 153, 232–240. 10.1016/j.polymer.2018.08.019. [DOI] [Google Scholar]
  36. Pal R. K.; Kurland N. E.; Jiang C.; Kundu S. C.; Zhang N.; Yadavalli V. K. Fabrication of precise shape-defined particles of silk proteins using photolithography. Eur. Polym. J. 2016, 85, 421–430. 10.1016/j.eurpolymj.2016.10.038. [DOI] [Google Scholar]
  37. Kurland N. E.; Dey T.; Kundu S. C.; Yadavalli V. K. Precise Patterning of Silk Microstructures Using Photolithography. Adv. Mater. 2013, 25 (43), 6207–6212. 10.1002/adma.201302823. [DOI] [PubMed] [Google Scholar]
  38. Youn Y. H.; Pradhan S.; da Silva L. P.; Kwon I. K.; Kundu S. C.; Reis R. L.; Yadavalli V. K.; Correlo V. M. Micropatterned Silk-Fibroin/Eumelanin Composite Films for Bioelectronic Applications. ACS Biomater. Sci. Eng. 2021, 7 (6), 2466–2474. 10.1021/acsbiomaterials.1c00216. [DOI] [PubMed] [Google Scholar]
  39. Ryu S.; Kim H. H.; Park Y. H.; Lin C. C.; Um I. C.; Ki C. S. Dual mode gelation behavior of silk fibroin microgel embedded poly(ethylene glycol) hydrogels. J. Mater. Chem. B 2016, 4 (26), 4574–4584. 10.1039/C6TB00896H. [DOI] [PubMed] [Google Scholar]
  40. Gong D.; Lin Q.; Shao Z.; Chen X.; Yang Y. Preparing 3D-printable silk fibroin hydrogels with robustness by a two-step crosslinking method. RSC Adv. 2020, 10 (45), 27225–27234. 10.1039/D0RA04789A. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Cheng Y.; Koh L.-D.; Li D.; Ji B.; Han M.-Y.; Zhang Y.-W. On the strength of β-sheet crystallites of Bombyx mori silk fibroin. J. R. Soc., Interface 2014, 11 (96), 20140305. 10.1098/rsif.2014.0305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. a Saxena T.; Karumbaiah L.; Valmikinathan C. M.. Proteins and Poly(Amino Acids). In Natural and Synthetic Biomedical Polymers; Kumbar S. G., Laurencin C. T., Deng M., Eds.; Elsevier, 2014; Chapter 3, pp 43–65. [Google Scholar]; b Vollrath F.; Knight D. P. Liquid crystalline spinning of spider silk. Nature 2001, 410 (6828), 541–548. 10.1038/35069000. [DOI] [PubMed] [Google Scholar]; c Kaplan D.; Adams W. W.; Farmer B.; Viney C.. Silk: biology, structure, properties, and genetics; ACS Publications, 1994. [Google Scholar]
  43. Agostinacchio F.; Mu X.; Dirè S.; Motta A.; Kaplan D. L. In Situ 3D Printing: Opportunities with Silk Inks. Trends Biotechnol. 2021, 39 (7), 719–730. 10.1016/j.tibtech.2020.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Van Vlierberghe S.; Dubruel P.; Schacht E. Biopolymer-Based Hydrogels As Scaffolds for Tissue Engineering Applications: A Review. Biomacromolecules 2011, 12 (5), 1387–1408. 10.1021/bm200083n. [DOI] [PubMed] [Google Scholar]
  45. Naskar D.; Sapru S.; Ghosh A. K.; Reis R. L.; Dey T.; Kundu S. C. Nonmulberry silk proteins: multipurpose ingredient in bio-functional assembly. Biomed. Mater. 2021, 16 (6), 062002. 10.1088/1748-605X/ac20a0. [DOI] [PubMed] [Google Scholar]; Reddy N.; Yang Y.. Non-mulberry Silk Fibers. In Innovative Biofibers from Renewable Resources; Reddy N., Yang Y., Eds.; Springer: Berlin, Heidelberg, 2015; pp 165–174. [Google Scholar]
  46. Winkler S.; Kaplan D. L. Molecular biology of spider silk. Rev. Mol. Biotechnol. 2000, 74 (2), 85–93. 10.1016/S1389-0352(00)00005-2. [DOI] [PubMed] [Google Scholar]
  47. Costa F.; Silva R.; Boccaccini A. R.. Fibrous protein-based biomaterials (silk, keratin, elastin, and resilin proteins) for tissue regeneration and repair. In Peptides and Proteins as Biomaterials for Tissue Regeneration and Repair; Barbosa M. A., Martins M. C. L., Eds.; Woodhead Publishing, 2018; Chapter 7, pp 175–204. [Google Scholar]
  48. Saric M.; Scheibel T. Two-in-One Spider Silk Protein with Combined Mechanical Features in All-Aqueous Spun Fibers. Biomacromolecules 2023, 24 (4), 1744–1750. 10.1021/acs.biomac.2c01500. [DOI] [PubMed] [Google Scholar]
  49. Zheng H.; Zuo B. Functional silk fibroin hydrogels: preparation, properties and applications. J. Mater. Chem. B 2021, 9 (5), 1238–1258. 10.1039/D0TB02099K. [DOI] [PubMed] [Google Scholar]
  50. Naghashzargar E.; Farè S.; Catto V.; Bertoldi S.; Semnani D.; Karbasi S.; Tanzi M. C. Nano/micro hybrid scaffold of PCL or P3HB nanofibers combined with silk fibroin for tendon and ligament tissue engineering. J. Appl. Biomater. Funct. Mater. 2015, 13 (2), 156–168. 10.5301/jabfm.5000216. [DOI] [PubMed] [Google Scholar]
  51. Vepari C.; Kaplan D. L. Silk as a Biomaterial. Prog. Polym. Sci. 2007, 32 (8–9), 991–1007. 10.1016/j.progpolymsci.2007.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Gholipourmalekabadi M.; Sapru S.; Samadikuchaksaraei A.; Reis R. L.; Kaplan D. L.; Kundu S. C. Silk fibroin for skin injury repair: Where do things stand?. Adv. Drug Delivery Rev. 2020, 153, 28–53. 10.1016/j.addr.2019.09.003. [DOI] [PubMed] [Google Scholar]
  53. Murphy A. R.; Kaplan D. L. Biomedical applications of chemically-modified silk fibroin. J. Mater. Chem. 2009, 19 (36), 6443–6450. 10.1039/b905802h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Sun W.; Gregory D. A.; Tomeh M. A.; Zhao X. Silk Fibroin as a Functional Biomaterial for Tissue Engineering. Int. J. Mol. Sci. 2021, 22 (3), 1499. 10.3390/ijms22031499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Lefèvre T.; Rousseau M.-E.; Pézolet M. Protein Secondary Structure and Orientation in Silk as Revealed by Raman Spectromicroscopy. Biophys. J. 2007, 92 (8), 2885–2895. 10.1529/biophysj.106.100339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hu X.; Kaplan D.; Cebe P. Dynamic Protein–Water Relationships during β-Sheet Formation. Macromolecules 2008, 41 (11), 3939–3948. 10.1021/ma071551d. [DOI] [Google Scholar]
  57. Percot A.; Colomban P.; Paris C.; Dinh H. M.; Wojcieszak M.; Mauchamp B. Water dependent structural changes of silk from Bombyx mori gland to fibre as evidenced by Raman and IR spectroscopies. Vib. Spectrosc. 2014, 73, 79–89. 10.1016/j.vibspec.2014.05.004. [DOI] [Google Scholar]
  58. Asakura T. Structure of Silk I (Bombyx mori Silk Fibroin before Spinning) -Type II β-Turn, Not α-Helix. Molecules 2021, 26, 3706. 10.3390/molecules26123706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Vass E.; Hollósi M.; Besson F.; Buchet R. Vibrational Spectroscopic Detection of Beta- and Gamma-Turns in Synthetic and Natural Peptides and Proteins. Chem. Rev. 2003, 103 (5), 1917–1954. 10.1021/cr000100n. [DOI] [PubMed] [Google Scholar]
  60. Hong H.; Lee O. J.; Lee Y. J.; Lee J. S.; Ajiteru O.; Lee H.; Suh Y. J.; Sultan M. T.; Kim S. H.; Park C. H. Cytocompatibility of Modified Silk Fibroin with Glycidyl Methacrylate for Tissue Engineering and Biomedical Applications. Biomolecules 2021, 11 (1), 35. 10.3390/biom11010035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Li J.; Du X.; Hashim S.; Shy A.; Xu B. Aromatic–Aromatic Interactions Enable α-Helix to β-Sheet Transition of Peptides to Form Supramolecular Hydrogels. J. Am. Chem. Soc. 2017, 139 (1), 71–74. 10.1021/jacs.6b11512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Tanaka K.; Kajiyama N.; Ishikura K.; Waga S.; Kikuchi A.; Ohtomo K.; Takagi T.; Mizuno S. Determination of the site of disulfide linkage between heavy and light chains of silk fibroin produced by Bombyx mori. Biochim. Biophys. Acta - Protein Structure and Molecular Enzymology 1999, 1432 (1), 92–103. 10.1016/S0167-4838(99)00088-6. [DOI] [PubMed] [Google Scholar]
  63. Rastogi S.; Kandasubramanian B. Processing trends of silk fibers: Silk degumming, regeneration and physical functionalization. J. Text. Inst. 2020, 111 (12), 1794–1810. 10.1080/00405000.2020.1727269. [DOI] [Google Scholar]
  64. Echeverri-Correa E.; Grajales-Lopera D. O.; Gutierrez-Restrepo S.; Ossa-Orozco C. P. Effective sericin-fibroin separation from Bombyx mori silkworms fibers and low-cost salt removal from fibroin solution. Rev. Fac. Ing., Univ. Antioquia 2019, 94, 97–101. 10.17533/udea.redin.20190731. [DOI] [Google Scholar]
  65. Khan M. M. R.; Tsukada M.; Gotoh Y.; Morikawa H.; Freddi G.; Shiozaki H. Physical properties and dyeability of silk fibers degummed with citric acid. Bioresour. Technol. 2010, 101 (21), 8439–8445. 10.1016/j.biortech.2010.05.100. [DOI] [PubMed] [Google Scholar]
  66. Gulrajani M. L.; Sinha S. Studies in degumming of silk with aliphatic amines. J. Soc. Dyers Colour. 1993, 109 (7–8), 256–260. 10.1111/j.1478-4408.1993.tb01571.x. [DOI] [Google Scholar]
  67. Feng Y.; Lin J.; Niu L.; Wang Y.; Cheng Z.; Sun X.; Li M. High Molecular Weight Silk Fibroin Prepared by Papain Degumming. Polymers 2020, 12 (9), 2105. 10.3390/polym12092105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Wang H. Y.; Zhang Y. Q.; Wei Z. G. Dissolution and processing of silk fibroin for materials science. Crit. Rev. Biotechnol. 2021, 41 (3), 406–424. 10.1080/07388551.2020.1853030. [DOI] [PubMed] [Google Scholar]
  69. Wang W.; Pan Y.; Gong K.; Zhou Q.; Zhang T.; Li Q. A comparative study of ultrasonic degumming of silk sericin using citric acid, sodium carbonate and papain. Color. Technol. 2019, 135 (3), 195–201. 10.1111/cote.12392. [DOI] [Google Scholar]
  70. Lo C.-H.; Chao Y. Degumming of SilkFibers by CO2 Supercritical Fluid. J. Mater. Sci. Chem. Eng. 2017, 5, 1–8. 10.4236/msce.2017.54001. [DOI] [Google Scholar]
  71. Cao T.-T.; Wang Y.-J.; Zhang Y.-Q. Effect of Strongly Alkaline Electrolyzed Water on Silk Degumming and the Physical Properties of the Fibroin Fiber. PLoS One 2013, 8 (6), e65654. 10.1371/journal.pone.0065654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. a Bucciarelli A.; Pal R. K.; Maniglio D.; Quaranta A.; Mulloni V.; Motta A.; Yadavalli V. K. Fabrication of Nanoscale Patternable Films of Silk Fibroin Using Benign Solvents. Macromol. Mater. Eng. 2017, 302 (7), 1700110. 10.1002/mame.201700110. [DOI] [Google Scholar]; b Marsano E.; Canetti M.; Conio G.; Corsini P.; Freddi G. Fibers based on cellulose–silk fibroin blend. J. Appl. Polym. Sci. 2007, 104 (4), 2187–2196. 10.1002/app.24856. [DOI] [Google Scholar]
  73. Hong H.; Seo Y. B.; Kim D. Y.; Lee J. S.; Lee Y. J.; Lee H.; Ajiteru O.; Sultan M. T.; Lee O. J.; Kim S. H.; et al. Digital light processing 3D printed silk fibroin hydrogel for cartilage tissue engineering. Biomaterials 2020, 232, 119679. 10.1016/j.biomaterials.2019.119679. [DOI] [PubMed] [Google Scholar]
  74. a Xie F.; Shao H.; Hu X. Effect of Storage Time and Concentration on Structure of Regenerated Silk Fibroin Solution. Int. J. Mod. Phys. B 2006, 20 (25n27), 3878–3883. 10.1142/S0217979206040520. [DOI] [Google Scholar]; b Yin J.; Chen E.; Porter D.; Shao Z. Enhancing the Toughness of Regenerated Silk Fibroin Film through Uniaxial Extension. Biomacromolecules 2010, 11 (11), 2890–2895. 10.1021/bm100643q. [DOI] [PubMed] [Google Scholar]; c Kook G.; Jeong S.; Kim S. H.; Kim M. K.; Lee S.; Cho I.-J.; Choi N.; Lee H. J. Wafer-Scale Multilayer Fabrication for Silk Fibroin-Based Microelectronics. ACS Appl. Mater. Interfaces 2019, 11 (1), 115–124. 10.1021/acsami.8b13170. [DOI] [PubMed] [Google Scholar]
  75. Wang Q.; Chen Q.; Yang Y.; Shao Z. Effect of Various Dissolution Systems on the Molecular Weight of Regenerated Silk Fibroin. Biomacromolecules 2013, 14 (1), 285–289. 10.1021/bm301741q. [DOI] [PubMed] [Google Scholar]
  76. a Wöltje M.; Kölbel A.; Aibibu D.; Cherif C. A Fast and Reliable Process to Fabricate Regenerated Silk Fibroin Solution from Degummed Silk in 4 h. Int. J. Mol. Sci. 2021, 22 (19), 10565. 10.3390/ijms221910565. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Tweedie A. S. A Study of the Viscosity Method for the Determination of Damage in Silk. Can. J. Res. 1938, 16b (4), 134–150. 10.1139/cjr38b-020. [DOI] [Google Scholar]
  77. a Gavrilova N. A.; Borzenok S. A.; Revishchin A. V.; Tishchenko O. E.; Ostrovkiy D. S.; Bobrova M. M.; Safonova L. A.; Efimov A. E.; Agapova O. I.; Agammedov M. B.; et al. The effect of biodegradable silk fibroin-based scaffolds containing glial cell line-derived neurotrophic factor (GDNF) on the corneal regeneration process. Int. J. Biol. Macromol. 2021, 185, 264–276. 10.1016/j.ijbiomac.2021.06.040. [DOI] [PubMed] [Google Scholar]; b Xu C.; Xia Y.; Wang L.; Nan X.; Hou J.; Guo Y.; Meng K.; Lian J.; Zhang Y.; Wu F.; et al. Polydopamine-assisted immobilization of silk fibroin and its derived peptide on chemically oxidized titanium to enhance biological activity in vitro. Int. J. Biol. Macromol. 2021, 185, 1022–1035. 10.1016/j.ijbiomac.2021.06.160. [DOI] [PubMed] [Google Scholar]; c Akrami-Hasan-Kohal M.; Eskandari M.; Solouk A. Silk fibroin hydrogel/dexamethasone sodium phosphate loaded chitosan nanoparticles as a potential drug delivery system. Colloids Surf., B 2021, 205, 111892. 10.1016/j.colsurfb.2021.111892. [DOI] [PubMed] [Google Scholar]
  78. a Sohn S.; Gido S. P. Wet-Spinning of Osmotically Stressed Silk Fibroin. Biomacromolecules 2009, 10 (8), 2086–2091. 10.1021/bm900169z. [DOI] [PubMed] [Google Scholar]; b Kapoor S.; Kundu S. C. Silk protein-based hydrogels: Promising advanced materials for biomedical applications. Acta Biomater. 2016, 31, 17–32. 10.1016/j.actbio.2015.11.034. [DOI] [PubMed] [Google Scholar]; c Nazarov R.; Jin H.-J.; Kaplan D. L. Porous 3-D Scaffolds from Regenerated Silk Fibroin. Biomacromolecules 2004, 5 (3), 718–726. 10.1021/bm034327e. [DOI] [PubMed] [Google Scholar]
  79. Unger R. E.; Wolf M.; Peters K.; Motta A.; Migliaresi C.; James Kirkpatrick C. Growth of human cells on a non-woven silk fibroin net: a potential for use in tissue engineering. Biomaterials 2004, 25 (6), 1069–1075. 10.1016/S0142-9612(03)00619-7. [DOI] [PubMed] [Google Scholar]
  80. a Rajkhowa R.; Wang L.; Kanwar J. R.; Wang X. Molecular weight and secondary structure change in eri silk during alkali degumming and powdering. J. Appl. Polym. Sci. 2011, 119 (3), 1339–1347. 10.1002/app.31981. [DOI] [Google Scholar]; b Yang H.; Wang Z.; Wang M.; Li C. Structure and properties of silk fibroin aerogels prepared by non-alkali degumming process. Polymer 2020, 192, 122298. 10.1016/j.polymer.2020.122298. [DOI] [Google Scholar]; c Dou H.; Zuo B. Effect of sodium carbonate concentrations on the degumming and regeneration process of silk fibroin. J. Text. Inst. 2015, 106 (3), 311–319. 10.1080/00405000.2014.919065. [DOI] [Google Scholar]
  81. Gulrajanid M. L.; Sethi S.; Gupta S. Some studies in degumming of silk with organic acids. J. Soc. Dyers Colour. 1992, 108 (2), 79–86. 10.1111/j.1478-4408.1992.tb01420.x. [DOI] [Google Scholar]
  82. Locatelli G.; Ponzio C.; Bari E. Chapter 2 Silk. Silk-based Drug Delivery Systems. R. Soc. Chem. 2020, 25–63. 10.1039/9781839162664-00025. [DOI] [Google Scholar]
  83. a Yamada H.; Nakao H.; Takasu Y.; Tsubouchi K. Preparation of undegraded native molecular fibroin solution from silkworm cocoons. Mater. Sci. Eng., C 2001, 14 (1), 41–46. 10.1016/S0928-4931(01)00207-7. [DOI] [Google Scholar]; b Ho M.-p.; Wang H.; Lau K.-t.; Lee J.-h.; Hui D. Interfacial bonding and degumming effects on silk fibre/polymer biocomposites. Composites, Part B 2012, 43 (7), 2801–2812. 10.1016/j.compositesb.2012.04.042. [DOI] [Google Scholar]
  84. Zhang J.; Zheng H.; Zheng L. Effect of treatment temperature on structures and properties of flax rove in supercritical carbon dioxide. Text. Res. J. 2018, 88 (2), 155–166. 10.1177/0040517516676068. [DOI] [Google Scholar]
  85. Chen G.; Kawazoe N.; Ito Y.. Photo-Crosslinkable Hydrogels for Tissue Engineering Applications. In Photochemistry for Biomedical Applications: From Device Fabrication to Diagnosis and Therapy; Ito Y., Ed.; Springer: Singapore, 2018; pp 277–300. [Google Scholar]
  86. Mu X.; Sahoo J. K.; Cebe P.; Kaplan D. L. Photo-Crosslinked Silk Fibroin for 3D Printing. Polymers 2020, 12 (12), 2936. 10.3390/polym12122936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. a Whittaker J. L.; Choudhury N. R.; Dutta N. K.; Zannettino A. Facile and rapid ruthenium mediated photo-crosslinking of Bombyx mori silk fibroin. J. Mater. Chem. B 2014, 2 (37), 6259–6270. 10.1039/C4TB00698D. [DOI] [PubMed] [Google Scholar]; b Bjork J. W.; Johnson S. L.; Tranquillo R. T. Ruthenium-catalyzed photo cross-linking of fibrin-based engineered tissue. Biomaterials 2011, 32 (10), 2479–2488. 10.1016/j.biomaterials.2010.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Das A.; Saikia C. N.; Hussain S. Grafting of methyl methacrylate (MMA) onto Antheraea assama silk fiber. J. Appl. Polym. Sci. 2001, 81 (11), 2633–2641. 10.1002/app.1707. [DOI] [Google Scholar]
  89. Lee T. Y.; Roper T. M.; Jonsson E. S.; Kudyakov I.; Viswanathan K.; Nason C.; Guymon C. A.; Hoyle C. E. The kinetics of vinyl acrylate photopolymerization. Polymer 2003, 44 (10), 2859–2865. 10.1016/S0032-3861(03)00213-1. [DOI] [Google Scholar]
  90. Bessonov I. V.; Rochev Y. A.; Arkhipova Y.; Kopitsyna M. N.; Bagrov D. V.; Karpushkin E. A.; Bibikova T. N.; Moysenovich A. M.; Soldatenko A. S.; Nikishin I. I.; et al. Fabrication of hydrogel scaffolds via photocrosslinking of methacrylated silk fibroin. Biomed. Mater. 2019, 14 (3), 034102. 10.1088/1748-605X/ab04e0. [DOI] [PubMed] [Google Scholar]
  91. a Zhu K.; Chen N.; Liu X.; Mu X.; Zhang W.; Wang C.; Zhang Y. S. A General Strategy for Extrusion Bioprinting of Bio-Macromolecular Bioinks through Alginate-Templated Dual-Stage Crosslinking. Macromol. Biosci. 2018, 18 (9), 1800127. 10.1002/mabi.201800127. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Noshadi I.; Hong S.; Sullivan K. E.; Shirzaei Sani E.; Portillo-Lara R.; Tamayol A.; Shin S. R.; Gao A. E.; Stoppel W. L.; Black Iii L. D.; et al. In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels. Biomater. Sci. 2017, 5 (10), 2093–2105. 10.1039/C7BM00110J. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Ghalei S.; Handa H. A review on antibacterial silk fibroin-based biomaterials: current state and prospects. Mater. Today Chem. 2022, 23, 100673. 10.1016/j.mtchem.2021.100673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Tang X.; Chen X.; Zhang S.; Gu X.; Wu R.; Huang T.; Zhou Z.; Sun C.; Ling J.; Liu M.; et al. Silk-Inspired In Situ Hydrogel with Anti-Tumor Immunity Enhanced Photodynamic Therapy for Melanoma and Infected Wound Healing. Adv. Funct. Mater. 2021, 31 (17), 2101320. 10.1002/adfm.202101320. [DOI] [Google Scholar]
  94. Li X.; Zhang J.; Kawazoe N.; Chen G. Fabrication of Highly Crosslinked Gelatin Hydrogel and Its Influence on Chondrocyte Proliferation and Phenotype. Polymers 2017, 9 (8), 309. 10.3390/polym9080309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Mondal M.; Trivedy K.; Nirmal Kumar S. The silk protein, sercin and fibroin in silkwirm, Bombyx mori linn, a Review. Casp. J. Environ. Sci. 2007, 5 (2), 63–76. [Google Scholar]
  96. Reis A. V.; Fajardo A. R.; Schuquel I. T. A.; Guilherme M. R.; Vidotti G. J.; Rubira A. F.; Muniz E. C. Reaction of Glycidyl Methacrylate at the Hydroxyl and Carboxylic Groups of Poly(vinyl alcohol) and Poly(acrylic acid): Is This Reaction Mechanism Still Unclear?. J. Org. Chem. 2009, 74 (10), 3750–3757. 10.1021/jo900033c. [DOI] [PubMed] [Google Scholar]
  97. Walsh C. M.; Wychowaniec J. K.; Costello L.; Brougham D. F.; Dooley D. An In Vitro and Ex Vivo Analysis of the Potential of GelMA Hydrogels as a Therapeutic Platform for Preclinical Spinal Cord Injury. Adv. Healthcare Mater. 2023, 2300951. 10.1002/adhm.202300951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Kim H.; Jeong J. H.; Fendereski M.; Lee H.-S.; Kang D. Y.; Hur S. S.; Amirian J.; Kim Y.; Pham N. T.; Suh N.; et al. Heparin-Mimicking Polymer-Based In Vitro Platform Recapitulates In Vivo Muscle Atrophy Phenotypes. Int. J. Mol. Sci. 2021, 22, 2488. 10.3390/ijms22052488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Spearman B. S.; Agrawal N. K.; Rubiano A.; Simmons C. S.; Mobini S.; Schmidt C. E. Tunable methacrylated hyaluronic acid-based hydrogels as scaffolds for soft tissue engineering applications. J. Biomed. Mater. Res., Part A 2020, 108 (2), 279–291. 10.1002/jbm.a.36814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Göckler T.; Haase S.; Kempter X.; Pfister R.; Maciel B. R.; Grimm A.; Molitor T.; Willenbacher N.; Schepers U. Tuning Superfast Curing Thiol-Norbornene-Functionalized Gelatin Hydrogels for 3D Bioprinting. Adv. Healthcare Mater. 2021, 10 (14), 2100206. 10.1002/adhm.202100206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Wang Z.; Chen W.; Cui Z.; He K.; Yu W. Studies on photoyellowing of silk fibroin and alteration of its tyrosine content. J. Text. Inst. 2016, 107 (4), 413–419. 10.1080/00405000.2015.1034933. [DOI] [Google Scholar]
  102. Bandyopadhyay A.; Mandal B. B.; Bhardwaj N. 3D bioprinting of photo-crosslinkable silk methacrylate (SilMA)-polyethylene glycol diacrylate (PEGDA) bioink for cartilage tissue engineering. J. Biomed. Mater. Res., Part A 2022, 110 (4), 884–898. 10.1002/jbm.a.37336. [DOI] [PubMed] [Google Scholar]
  103. Liang J.; Zhang X.; Chen Z.; Li S.; Yan C. Thiol–Ene Click Reaction Initiated Rapid Gelation of PEGDA/Silk Fibroin Hydrogels. Polymers 2019, 11 (12), 2102. 10.3390/polym11122102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Shin S. R.; Aghaei-Ghareh-Bolagh B.; Dang T. T.; Topkaya S. N.; Gao X.; Yang S. Y.; Jung S. M.; Oh J. H.; Dokmeci M. R.; Tang X.; et al. Cell-laden Microengineered and Mechanically Tunable Hybrid Hydrogels of Gelatin and Graphene Oxide. Adv. Mater. 2013, 25 (44), 6385–6391. 10.1002/adma.201301082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Céspedes-Valenzuela D. N.; Sánchez-Rentería S.; Cifuentes J.; Gantiva-Diaz M.; Serna J. A.; Reyes L. H.; Ostos C.; Cifuentes-De la Portilla C.; Muñoz-Camargo C.; Cruz J. C. Preparation and Characterization of an Injectable and Photo-Responsive Chitosan Methacrylate/Graphene Oxide Hydrogel: Potential Applications in Bone Tissue Adhesion and Repair. Polymers 2022, 14 (1), 126. 10.3390/polym14010126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. a Wychowaniec J. K.; Iliut M.; Zhou M.; Moffat J.; Elsawy M. A.; Pinheiro W. A.; Hoyland J. A.; Miller A. F.; Vijayaraghavan A.; Saiani A. Designing Peptide/Graphene Hybrid Hydrogels through Fine-Tuning of Molecular Interactions. Biomacromolecules 2018, 19 (7), 2731–2741. 10.1021/acs.biomac.8b00333. [DOI] [PubMed] [Google Scholar]; b Rokaya D.; Srimaneepong V.; Qin J.; Siraleartmukul K.; Siriwongrungson V. Graphene Oxide/Silver Nanoparticle Coating Produced by Electrophoretic Deposition Improved the Mechanical and Tribological Properties of NiTi Alloy for Biomedical Applications. J. Nanosci. Nanotechnol. 2019, 19 (7), 3804–3810. 10.1166/jnn.2019.16327. [DOI] [PubMed] [Google Scholar]
  107. Oral C. B.; Yetiskin B.; Okay O. Stretchable silk fibroin hydrogels. Int. J. Biol. 2020, 161, 1371–1380. 10.1016/j.ijbiomac.2020.08.040. [DOI] [PubMed] [Google Scholar]
  108. Ng P.; Pinho A. R.; Gomes M. C.; Demidov Y.; Krakor E.; Grume D.; Herb M.; Lê K.; Mano J.; Mathur S.; et al. Fabrication of Antibacterial, Osteo-Inductor 3D Printed Aerogel-Based Scaffolds by Incorporation of Drug Laden Hollow Mesoporous Silica Microparticles into the Self-Assembled Silk Fibroin Biopolymer. Macromol. Biosci. 2022, 22 (4), 2100442. 10.1002/mabi.202100442. [DOI] [PubMed] [Google Scholar]
  109. a Zhou Y.; Quan G.; Wu Q.; Zhang X.; Niu B.; Wu B.; Huang Y.; Pan X.; Wu C. Mesoporous silica nanoparticles for drug and gene delivery. Acta Pharm. Sin. 2018, 8 (2), 165–177. 10.1016/j.apsb.2018.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Rahnama Ghahfarokhi M.; Amirian J. Hybrid Materials based on Silica Nanostructures for Biomedical Scaffolds (Bone Regeneration) and Drug Delivery. Mater. Res. Found. 2021, 87, 103–120. 10.21741/9781644901076-4. [DOI] [Google Scholar]
  110. a Niculescu V.-C. Mesoporous Silica Nanoparticles for Bio-Applications. Front. Mater. 2020, 7, 36. 10.3389/fmats.2020.00036. [DOI] [Google Scholar]; b Li Z.; Zhang Y.; Feng N. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert Opin. Drug Delivery 2019, 16 (3), 219–237. 10.1080/17425247.2019.1575806. [DOI] [PubMed] [Google Scholar]; c Mahony D.; Cavallaro A. S.; Stahr F.; Mahony T. J.; Qiao S. Z.; Mitter N. Mesoporous Silica Nanoparticles Act as a Self-Adjuvant for Ovalbumin Model Antigen in Mice. Small 2013, 9 (18), 3138–3146. 10.1002/smll.201300012. [DOI] [PubMed] [Google Scholar]; d Lee J. Y.; Kim M. K.; Nguyen T. L.; Kim J. Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine. ACS Appl. Mater. Interfaces 2020, 12 (31), 34658–34666. 10.1021/acsami.0c09484. [DOI] [PubMed] [Google Scholar]
  111. Schwab A.; Levato R.; D’Este M.; Piluso S.; Eglin D.; Malda J. Printability and Shape Fidelity of Bioinks in 3D Bioprinting. Chem. Rev. (Washington, DC, U. S.) 2020, 120 (19), 11028–11055. 10.1021/acs.chemrev.0c00084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Velu R.; Jayashankar D. K.; Subburaj K.. Additive processing of biopolymers for medical applications. In Additive Manufacturing; Pou J., Riveiro A., Davim J. P., Eds.; Elsevier, 2021; Chapter 20, pp 635–659. [Google Scholar]
  113. Geckil H.; Xu F.; Zhang X.; Moon S.; Demirci U. Engineering hydrogels as extracellular matrix mimics. Nanomed (London, England) 2010, 5 (3), 469–484. 10.2217/nnm.10.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Gu X.; Chen X.; Tang X.; Zhou Z.; Huang T.; Yang Y.; Ling J. Pure-silk fibroin hydrogel with stable aligned micropattern toward peripheral nerve regeneration. Nanotechnol. Rev. 2021, 10 (1), 10–19. 10.1515/ntrev-2021-0002. [DOI] [Google Scholar]
  115. Elammari F. A.; Daniels S.. Polymer Surface Modification Using Atmospheric Pressure Plasma. In Encyclopedia of Materials: Plastics and Polymers; Hashmi M. S. J., Ed.; Elsevier, 2022; pp 575–590. [Google Scholar]
  116. Wolf M. P.; Salieb-Beugelaar G. B.; Hunziker P. PDMS with designer functionalities—Properties, modifications strategies, and applications. Prog. Polym. Sci. 2018, 83, 97–134. 10.1016/j.progpolymsci.2018.06.001. [DOI] [Google Scholar]
  117. Tran K. T. M.; Nguyen T. D. Lithography-based methods to manufacture biomaterials at small scales. J. Sci.: Adv. Mater. Devices 2017, 2 (1), 1–14. 10.1016/j.jsamd.2016.12.001. [DOI] [Google Scholar]
  118. Xu M.; Pradhan S.; Agostinacchio F.; Pal R. K.; Greco G.; Mazzolai B.; Pugno N. M.; Motta A.; Yadavalli V. K. Easy, Scalable, Robust, Micropatterned Silk Fibroin Cell Substrates. Adv. Mater. Interfaces 2019, 6 (8), 1801822. 10.1002/admi.201801822. [DOI] [Google Scholar]
  119. Aljohani W.; Ullah M. W.; Zhang X.; Yang G. Bioprinting and its applications in tissue engineering and regenerative medicine. Int. J. Biol. Macromol. 2018, 107, 261–275. 10.1016/j.ijbiomac.2017.08.171. [DOI] [PubMed] [Google Scholar]
  120. Baimark Y.; Srihanam P.; Srisuwan Y.; Phinyocheep P. Preparation of porous silk fibroin microparticles by a water-in-oil emulsification-diffusion method. J. Appl. Polym. Sci. 2010, 118 (2), 1127–1133. 10.1002/app.32506. [DOI] [Google Scholar]
  121. Wani S. U.; Zargar M. I.; Masoodi M. H.; Alshehri S.; Alam P.; Ghoneim M. M.; Alshlowi A.; Shivakumar H. G.; Ali M.; Shakeel F. Silk Fibroin as an Efficient Biomaterial for Drug Delivery, Gene Therapy, and Wound Healing. Int. J. Mol. Sci. 2022, 23, 14421. 10.3390/ijms232214421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Xie M.; Fan D.; Li Y.; He X.; Chen X.; Chen Y.; Zhu J.; Xu G.; Wu X.; Lan P. Supercritical carbon dioxide-developed silk fibroin nanoplatform for smart colon cancer therapy. Int. J. Nanomed. 2017, 12, 7751–7761. 10.2147/IJN.S145012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Matthew S. A. L.; Rezwan R.; Kaewchuchuen J.; Perrie Y.; Seib F. P. Mixing and flow-induced nanoprecipitation for morphology control of silk fibroin self-assembly. RSC Adv. 2022, 12 (12), 7357–7373. 10.1039/D1RA07764C. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Xu S.; Wang L.; Liu Z. Molecularly Imprinted Polymer Nanoparticles: An Emerging Versatile Platform for Cancer Therapy. Angew. Chem., Int. Ed. 2021, 60 (8), 3858–3869. 10.1002/anie.202005309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Sinna J.; Numpaisal P.-o.; Ruksakulpiwat C.; Ruksakulpiwat Y. Extraction of silk fibroin and glycidyl methacrylate grafting on silk fibroin optimization of SF-g-GMA for meniscus tissue engineering. Mater. Today: Proc. 2021, 47, 3476–3479. 10.1016/j.matpr.2021.03.464. [DOI] [Google Scholar]
  126. Lu Y.; Huang X.; Yuting L.; Zhu R.; Zheng M.; Yang J.; Bai S. Silk Fibroin-Based Tough Hydrogels with Strong Underwater Adhesion for Fast Hemostasis and Wound Sealing. Biomacromolecules 2023, 24 (1), 319–331. 10.1021/acs.biomac.2c01157. [DOI] [PubMed] [Google Scholar]
  127. Spotnitz W. D.; Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 2008, 48 (7), 1502–1516. 10.1111/j.1537-2995.2008.01703.x. [DOI] [PubMed] [Google Scholar]
  128. Wang Y.; Wang X.; Shi J.; Zhu R.; Zhang J.; Zhang Z.; Ma D.; Hou Y.; Lin F.; Yang J.; et al. A Biomimetic Silk Fibroin/Sodium Alginate Composite Scaffold for Soft Tissue Engineering. Sci. Rep. 2016, 6 (1), 39477. 10.1038/srep39477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Koeppel A.; Stehling N.; Rodenburg C.; Holland C. Spinning Beta Silks Requires Both pH Activation and Extensional Stress. Adv. Funct. Mater. 2021, 31 (30), 2103295. 10.1002/adfm.202103295. [DOI] [Google Scholar]
  130. Abraham B. L.; Toriki E. S.; Tucker N. D. J.; Nilsson B. L. Electrostatic interactions regulate the release of small molecules from supramolecular hydrogels. J. Mater. Chem. B 2020, 8 (30), 6366–6377. 10.1039/D0TB01157F. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biomacromolecules are provided here courtesy of American Chemical Society

RESOURCES